Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

C3_URINARY_TRACT_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints C3_KIDNEY_NOTRENALPELVIS_EXALLC C3_RENAL_PELVIS_EXALLC C3_URETER_EXALLC C3_URINARY_TRACT_NAS_EXALLC	4709
6. Filter based on genotype QC (FinnGen only)	4709

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_URINARY_TRACT_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	C3_KIDNEY_NOTRENALPELVIS_EXALLC\|C3_RENAL_PELVIS_EXALLC\|C3_URETER_EXALLC\|C3_URINARY_TRACT_NAS_EXALLC
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4709	1644	3065
Unadjusted period prevalence (%)	1.08	0.56	1.35
Median age at first event (years)	67.64	66.42	68.29

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3459: Matched controls
34598

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

323.0

1012

JN4CD

NOMESCO Finland

Very extensive body CT

27.5

323.0

531

226

KAD01

NOMESCO Finland

Percutaneous endoscopic partial nephrectomy

326.7

323.0

377

197

Kela drug reimbursment

Sunitinib

+∞

323.0

339

B01AB10

ATC

tinzaparin; parenteral

15.5

323.0

799

655

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

4454.3

323.0

734

WX302

NOMESCO Finland

Thoracal epidural anesthesy

25.8

323.0

600

279

KAC10

NOMESCO Finland

Total nephrectomy with capsule

914.8

323.0

837

JN4BD

NOMESCO Finland

Extensive body CT

14.6

323.0

899

809

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

6.3

323.0

1009

2130

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

323.0

2842

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

292.1

323.0

2034

168

JN4AD

NOMESCO Finland

Body CT examination

23.4

323.0

887

502

130

Kela drug reimbursment

Malignant tumour

+∞

323.0

898

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

323.0

344

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

323.0

1413

KAD00

NOMESCO Finland

Partial nephrectomy

353.2

323.0

403

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

766.0

323.0

630

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

323.0

325

C61

ICD-10 Finland

Malignant neoplasm of prostate

332.4

323.0

329

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

11.6

312.1

616

633

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

3013.8

302.3

288

H02AB02

ATC

dexamethasone; systemic

40.5

297.1

377

104

L01XE04

ATC

[U] sunitinib; oral

+∞

294.0

278

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

2920.1

293.7

280

WF049

NOMESCO Finland

Radiotherapy of metastasis

1515.1

288.4

277

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

36.4

276.9

360

110

A03FA01

ATC

metoclopramide; systemic, rectal

5.9

266.4

852

1824

TPH07

NOMESCO Finland

Cathetrisation of artery

5.9

259.2

828

1764

WX408

NOMESCO Finland

General anesthesy, balanced

4.0

253.3

1332

4724

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

2447.0

249.8

239

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

247.9

235

B01AB05

ATC

enoxaparin; parenteral

3.4

217.9

1444

6007

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

321.4

208.9

210

KAC00

NOMESCO Finland

Nephrectomy

359.5

205.1

205

1502

Kela drug reimbursment

Cabozantinib

+∞

203.1

193

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

197.8

188

C64.80

ICD-10 Finland

Wilms tumour

+∞

196.7

187

A04AA02

ATC

granisetron; systemic, transdermal

299.5

195.2

197

3012

Kela drug reimbursment

Cabozantinib

+∞

194.6

185

Z51.5

ICD-10 Finland

Palliative care

11.6

184.0

357

339

U75

ICPC

Malignant neoplasm of kidney

+∞

181.9

173

UKC02

NOMESCO Finland

Cystoscopy

3.6

181.0

995

3476

159

Kela drug reimbursment

Pazopanib

+∞

172.3

164

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

3.2

172.1

1181

4848

R31

ICD-10 Finland

Unspecified haematuria

4.3

169.0

717

1982

XX3DW

NOMESCO Finland

Time consuming IT work

7.0

164.7

438

704

WZC30

NOMESCO Finland

Teaching

4.6

161.4

626

1578

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

160.7

153

8317/3-C64.9

ICD-O-3

Renal cell carcinoma, chromophobe type of kidney, NOS

+∞

159.6

152

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.6

158.5

1876

10703

116

Kela drug reimbursment

Prostate cancer

+∞

155.4

148

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

76.5

154.2

175

8120/3-C65.9

ICD-O-3

Transitional cell carcinoma, NOS, of renal pelvis

+∞

152.2

145

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

1565.6

152.2

147

7125

FHL

Nephrectomy (extrrafascial)

1539.8

150.1

145

N02AA05

ATC

oxycodone; systemic

3.8

149.2

728

2257

WX402

NOMESCO Finland

General anaesthesia

3.8

145.8

704

2159

N02AX02

ATC

tramadol; systemic, rectal

2.5

143.4

1769

10112

WF002

NOMESCO Finland

Radical radiotherapy

208.2

135.8

140

322

Kela drug reimbursment

Sunitinib

+∞

135.3

129

180

Kela drug reimbursment

Interferon alfa

+∞

132.1

126

L01XE26

ATC

[U] cabozantinib; oral

+∞

128.9

123

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

8.8

128.2

289

356

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

646.1

127.2

125

KCD02

NOMESCO Finland

Transurethral resection of bladder

36.9

125.4

162

D41.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Renal pelvis

192.8

125.4

130

KAC20

NOMESCO Finland

Nephroureterectomy

+∞

122.6

117

L01XE11

ATC

[U] pazopanib; oral

+∞

121.5

116

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

7.8

118.9

289

401

KA1AE

NOMESCO Finland

Kidney ultrasound examination

9.5

118.8

255

288

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

298.9

113.8

115

8000/3-C64.9

ICD-O-3

Neoplasm, malignant of kidney, NOS

+∞

113.1

108

1890B

ICD-9 Finland

Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,ADENOCARCINOMA]

+∞

112.1

107

JN3AD

NOMESCO Finland

Abdominal CT examination

4.4

111.1

441

1111

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

379.1

111.0

111

L01EX07

ATC

cabozantinib; oral

+∞

110.0

105

C66

ICD-10 Finland

Malignant neoplasm of ureter

+∞

108.9

104

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

84.3

108.9

122

115

Kela drug reimbursment

Breast cancer

+∞

105.7

101

158

Kela drug reimbursment

Everolimus

+∞

104.7

100

PJA12

NOMESCO Finland

Sentinel node biopsy

+∞

102.6

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

101.5

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

207.9

97.9

101

A04AA01

ATC

ondansetron; systemic, rectal

9.4

97.1

208

233

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

10.6

96.1

193

192

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.8

96.0

455

1337

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

953.7

95.4

ZX090

NOMESCO Finland

Other technic of radiotherapy

922.1

92.2

WF004

NOMESCO Finland

Palliative radiotherapy

879.9

88.1

N02BE01

ATC

paracetamol; systemic, rectal

2.4

87.6

2933

24039

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

438.2

86.5

NK6AN

NOMESCO Finland

Total body bone isotope imaging

55.2

85.7

102

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

4.1

85.4

360

950

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.3

83.4

475

1603

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

82.6

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

81.6

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

79.6

843

4136

KAC21

NOMESCO Finland

Percutaneous endoscopic nephroureterectomy

+∞

79.5

ZXC96

NOMESCO Finland

Robot assisted procedure

25.7

79.4

112

L02AE02

ATC

leuprorelin; implant, parenteral

45.3

78.7

R4110

NOMESCO Finland

Physiotherapy

2.2

78.0

984

5242

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

9.5

77.9

165

181

KA3LT

NOMESCO Finland

Njurlesion coagulation

270.0

77.8

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.5

76.6

688

3088

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

119.9

76.2

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

754.1

75.5

WW500

NOMESCO Finland

Blood transfusion

7.2

75.3

190

276

168

Kela drug reimbursment

Axitinib

+∞

74.2

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

14.3

72.9

126

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

72.1

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.9

71.4

247

533

L01BC06

ATC

capecitabine; oral

+∞

71.1

D30.0

ICD-10 Finland

Benign neoplasm: Kidney

17.0

70.7

114

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

74.5

70.4

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

5.8

70.1

210

384

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

17.3

69.3

111

WF003

NOMESCO Finland

Adjuvant radiotherapy

146.9

68.2

L01XE10

ATC

[U] everolimus; oral

+∞

65.8

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

649.9

65.1

8120/3-C66.9

ICD-O-3

Transitional cell carcinoma, NOS, of ureter

+∞

64.8

KAC01

NOMESCO Finland

Percutaneous endoscopic nephrectomy

220.6

63.3

Y77

ICPC

Malignant neoplasm prostate

217.2

62.3

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

618.8

62.0

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

61.6

GD1AD

NOMESCO Finland

Thorax CT examination

4.6

60.9

222

505

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.7

60.7

288

835

L02BB03

ATC

bicalutamide; oral

312.9

60.5

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

10.2

60.0

122

124

L03AA13

ATC

pegfilgrastim; parenteral

598.0

59.9

1890X

ICD-9 Finland

Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,EI HIST VAHV]

+∞

59.5

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.2

59.5

348

1183

S18

ICPC

Laceration/cut

1.8

58.8

1431

9610

N18.8

ICD-10 Finland

Other chronic renal failure

4.6

58.6

216

497

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

58.5

ZX070

NOMESCO Finland

Intensity modified radiotherapy

+∞

58.5

343

Kela drug reimbursment

Pazopanib

+∞

57.4

L03AA02

ATC

filgrastim; parenteral

53.3

57.0

UKB02

NOMESCO Finland

Retrograde ureteroscopy

10.9

56.7

111

105

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.9

56.4

251

688

C648

ICD-10 Finland

+∞

56.4

U14

ICPC

Kidney symptom/complaint

7.6

56.3

136

185

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

196.5

56.1

XKD00

NOMESCO Finland

Uroflowmetry

2.2

55.9

703

3658

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

556.6

55.7

L01XE17

ATC

[U] axitinib; oral

+∞

55.3

J01MA02

ATC

ciprofloxacin; systemic

1.8

55.2

1372

9218

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

79.0

55.1

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

117.9

53.9

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

53.7

453

1932

SPAT1153

SPAT

Removal of sutures

1.9

53.4

1105

6961

C08CA01

ATC

amlodipine; oral

1.8

53.3

1451

10000

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

525.6

52.6

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

52.2

198

Kela drug reimbursment

Sorafenib

+∞

52.2

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

84.3

52.0

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

14.8

51.4

L02BG04

ATC

letrozole; oral

31.0

50.3

ZX120

NOMESCO Finland

Intravenous

2.9

50.1

327

1194

A79

ICPC

Malignancy NOS

93.1

49.9

TK800

NOMESCO Finland

Hemodialysis

5.4

49.4

155

299

L01EX01

ATC

sunitinib; oral

+∞

49.1

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

5.0

48.8

165

346

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

14.6

48.8

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.2

48.6

558

2768

A11CC03

ATC

alfacalcidol; systemic

4.9

47.2

160

337

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

243.2

47.1

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

19.3

47.1

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.6

46.9

170

384

C50.99

ICD-10 Finland

Breast, unspecified

+∞

45.9

HAC20

NOMESCO Finland

Total mastectomy

162.1

45.9

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

31.0

45.9

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

8.7

45.9

101

119

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.5

45.8

387

1645

ZXA05

NOMESCO Finland

Left side

1.8

45.7

947

5904

340

Kela drug reimbursment

Everolimus

+∞

44.9

8960/3-C64.9

ICD-O-3

Nephroblastoma, NOS, of kidney, NOS

+∞

44.9

D41.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Ureter

+∞

44.9

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

5.7

44.1

131

237

R50.9

ICD-10 Finland

Fever, unspecified

2.2

43.8

477

2298

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

43.8

J01MA12

ATC

levofloxacin; systemic

2.0

43.2

668

3737

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

42.8

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

217.5

42.0

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

41.7

A04AD12

ATC

aprepitant; systemic

+∞

41.7

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

17.4

41.1

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.4

40.0

152

360

WX110

NOMESCO Finland

Local anesthesy

1.6

39.9

1970

15574

M05BX04

ATC

denosumab; parenteral

3.7

39.9

184

519

L01XE05

ATC

[U] sorafenib; oral

+∞

39.6

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

6.3

39.5

108

176

M04AA01

ATC

allopurinol; systemic

2.0

39.0

593

3283

WX704

NOMESCO Finland

Intubation

2.8

38.8

269

1015

HA1AA

NOMESCO Finland

X-ray mammography

5.4

38.7

119

225

361

Kela drug reimbursment

Axitinib

+∞

38.6

ZXA00

NOMESCO Finland

Right side

1.7

37.7

966

6365

KA4AT

NOMESCO Finland

Cytology of kidney with ultrasound guidance

+∞

37.6

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

21.5

37.4

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

371.1

37.1

C03CA01

ATC

furosemide; systemic

1.6

37.0

1220

8619

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

6.3

36.9

101

165

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

36.5

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

36.0

582

3284

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

35.9

499

2658

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

186.8

35.8

HAB40

NOMESCO Finland

Wedge excision of mammary gland

20.7

35.7

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

35.5

A12AA04

ATC

calcium carbonate; oral

5.4

35.2

108

204

A02BC02

ATC

pantoprazole; systemic

1.6

35.2

2037

16509

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.2

35.2

199

656

L03AA04

ATC

67.3

35.0

B03XA02

ATC

darbepoetin alfa; parenteral

5.6

34.8

104

190

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

34.4

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

34.4

R93.4

ICD-10 Finland

Abnormal findings on diagnostic imaging of urinary organs

11.2

34.2

PHE70

NOMESCO Finland

Thrombectomy of inferior vena cava

340.3

34.0

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

7.0

33.8

124

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

11.2

33.7

V03AE01

ATC

polystyrene sulfonate; oral

5.7

33.5

179

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

33.4

1890A

ICD-9 Finland

Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,NEPHROBLASTOMA]

+∞

33.4

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

33.4

L02BA01

ATC

tamoxifen; oral

64.0

33.0

A04AA55

ATC

palonosetron, combinations; systemic

330.1

32.9

U06

ICPC

Haematuria

4.5

32.4

119

273

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

32.3

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

32.3

KH1AD

NOMESCO Finland

CT of urinary organs

3.6

32.3

154

447

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

5.2

32.2

102

200

BCA30

NOMESCO Finland

Unilateral adrenalectomy

40.5

32.1

KH1BD

NOMESCO Finland

Extensive urinary tract CT examination

9.0

31.8

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

114.4

31.7

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

5.1

31.5

101

201

205

Kela drug reimbursment

Chronic hypertension

1.6

31.5

1203

8733

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

31.4

599

3567

18900

ICD-8 Finland

Malignant neoplasm of other and unspecified urinary organs, Kidney, except pelvis

+∞

31.3

8120/3-C68.9

ICD-O-3

Transitional cell carcinoma, NOS, of urinary system, NOS

+∞

31.3

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

31.3

PJD43

NOMESCO Finland

Excision of aortic lymph nodes

+∞

31.3

Z85.5

ICD-10 Finland

Personal history of malignant neoplasm of urinary tract

+∞

31.3

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

6.5

31.1

128

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

31.1

996

6911

UKA02

NOMESCO Finland

Retrograde ureteronephroscopy

17.1

31.0

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

42.6

30.9

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

315.5

30.9

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

30.2

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

30.2

C68.0

ICD-10 Finland

Malignant neoplasm: Urethra

+∞

30.2

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

30.2

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

+∞

30.2

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

30.2

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

30.2

N28.1

ICD-10 Finland

Cyst of kidney

5.2

29.9

187

JN6AD

NOMESCO Finland

CT of torso and neck

14.0

29.8

KC1GB

NOMESCO Finland

Cystography with X-ray

28.9

29.8

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

29.2

938

6492

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

18.2

29.2

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

57.2

29.1

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

6.9

29.0

107

Z49.0

ICD-10 Finland

Preparatory care for dialysis

6.6

28.9

115

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

151.2

28.7

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

28.5

2137

17918

J01DB01

ATC

cefalexin; oral

1.5

28.5

2494

21654

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

28.2

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

28.2

2395A

ICD-9 Finland

Neoplasm of unspecified nature, Other genito-urinary organs

33.0

27.8

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

3.1

27.7

158

524

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.4

27.4

159

Z31.5

ICD-10 Finland

Genetic counselling

4.1

27.4

109

271

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.6

27.4

213

860

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.8

27.3

181

663

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

27.1

Z51.0

ICD-10 Finland

Radiotherapy session

+∞

27.1

AA1BD

NOMESCO Finland

Extensive CT of head and brain

4.5

27.1

227

L03AB05

ATC

interferon alfa-2b; parenteral

24.0

27.0

A06AH03

ATC

naloxegol; oral

14.7

26.9

KB1CG

NOMESCO Finland

Extensive MRI examination of urinary tract with high intensity magnet

75.7

26.8

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.3

26.7

263

1201

WX725

NOMESCO Finland

Noninvasive ventilation

2.8

26.6

175

639

R4190

NOMESCO Finland

Nutritional therapy

4.4

26.3

225

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.1

26.2

152

511

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

18.4

26.1

C50

ICD-10 Finland

Malignant neoplasm of breast

+∞

26.1

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

26.1

8010/3-C64.9

ICD-O-3

Carcinoma, NOS, of kidney, NOS

+∞

26.1

PC5DT

NOMESCO Finland

Embolisation of tumor of kidney

262.4

25.7

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

262.4

25.7

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

262.4

25.7

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

262.4

25.7

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

136.0

25.6

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.3

25.6

112

ZX136

NOMESCO Finland

Intravesicalis

15.9

25.4

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

28.6

25.4

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.3

25.3

229

B02AA02

ATC

tranexamic acid; systemic

2.1

25.1

322

1647

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

25.0

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

25.0

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

25.0

Z90.5

ICD-10 Finland

Acquired absence of kidney

58.4

25.0

J01EA01

ATC

trimethoprim; systemic

1.6

24.8

692

4579

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

56.4

24.0

U79

ICPC

Neoplasm urinary tract unspecified

+∞

24.0

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

+∞

24.0

KCC10

NOMESCO Finland

Cystoprostatectomy

+∞

24.0

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

24.0

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

24.0

L01EX03

ATC

pazopanib; oral

+∞

24.0

C90.0

ICD-10 Finland

Multiple myeloma

241.5

23.7

L03AB04

ATC

interferon alfa-2a; parenteral

23.8

23.4

N18.0

ICD-10 Finland

End-stage renal disease

4.6

23.3

182

G04CA02

ATC

tamsulosin; oral

1.5

23.0

984

7209

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

23.0

313

1640

C68.9

ICD-10 Finland

Malignant neoplasm: Urinary organ, unspecified

+∞

22.9

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

22.9

C68.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of urinary organs

+∞

22.9

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

231.4

22.6

ZZR00

NOMESCO Finland

Flap of skin

8.1

22.6

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

8.5

22.5

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

6.0

22.5

104

D41.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified

35.3

22.0

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

+∞

21.9

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

21.9

128

Kela drug reimbursment

Cancers of female genital organs

+∞

21.9

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

21.9

UJF32

NOMESCO Finland

Coloscopy

1.5

21.8

773

5416

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

221.2

21.6

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

221.2

21.6

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

15.3

21.5

A06AD11

ATC

lactulose; oral

1.7

21.1

522

3328

H05BX01

ATC

cinacalcet; oral

11.3

20.9

WC305

NOMESCO Finland

Simple therapy of local tumor recidive with biomodifiers

+∞

20.8

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

20.8

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

20.8

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

+∞

20.8

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

20.8

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

20.8

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

20.8

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

20.7

264

1348

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

211.1

20.6

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

211.1

20.6

M05BA02

ATC

clodronic acid; systemic

211.1

20.6

KA3CT

NOMESCO Finland

Biopsy of kidney under CT guidance

211.1

20.6

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

110.6

20.6

B01AB04

ATC

dalteparin; parenteral

2.5

20.5

169

703

ZX050

NOMESCO Finland

Stereotactic radiotherapy

41.9

20.4

D70.82

ICD-10 Finland

Drug-induced neutropenia

11.3

20.4

TKE00

NOMESCO Finland

Needle biopsy of prostate

3.0

20.3

122

420

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

20.2

206

954

TQW99

NOMESCO Finland

Other minor procedure on skin

2.8

20.1

135

498

PHN71

NOMESCO Finland

Excision of tumor mass from inferior vena cava

+∞

19.8

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

19.8

7126

FHL

Nephroureterectomy

+∞

19.8

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

19.8

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

19.8

C67

ICD-10 Finland

Malignant neoplasm of bladder

+∞

19.8

N02AA01

ATC

morphine; systemic, rectal

5.8

19.7

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

19.7

297

1615

JAH00

NOMESCO Finland

Laparotomy

3.4

19.6

287

JMA10

NOMESCO Finland

Transabdominal total splenectomy

16.4

19.6

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

19.6

202

941

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.8

19.6

132

490

R33

ICD-10 Finland

Retention of urine

1.9

19.5

322

1810

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.6

19.4

C02AC05

ATC

moxonidine; oral

2.3

19.4

193

884

BCA31

NOMESCO Finland

Endoscopic unilateral adrenalectomy

13.3

19.2

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.7

19.1

137

529

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

55.3

18.9

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

18.9

874

6461

TKW99

NOMESCO Finland

Other minor surgical procedure in urology

7.5

18.8

L01EK01

ATC

axitinib; oral

+∞

18.8

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

18.8

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

18.8

L02AB02

ATC

medroxyprogesterone; systemic (progestogens)

13.4

18.7

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

190.9

18.5

JLC10

NOMESCO Finland

Distal pancreatectomy

38.6

18.5

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.4

18.5

263

127

Kela drug reimbursment

Transplant complication

5.1

18.5

115

Z94.0

ICD-10 Finland

Kidney transplant status

5.5

18.2

100

137

Kela drug reimbursment

Uraemia requiring dialysis

5.6

18.2

WX882

NOMESCO Finland

High dependency care

2.9

18.0

109

379

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.6

17.8

130

507

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

17.7

D75

ICPC

Malignant neoplasm colon/rectum

+∞

17.7

1888X

ICD-9 Finland

Malignant neoplasm of bladder, Other specified sites of bladder

+∞

17.7

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

17.7

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

66.9

17.7

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

66.9

17.7

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.3

17.6

169

762

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

180.8

17.5

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

7.2

17.5

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

8.7

17.4

321

Kela drug reimbursment

Paricalcitol and cinacalcet

10.1

17.4

XJH00

NOMESCO Finland

Transanal ultrasonography

2.0

17.3

226

1162

OAB42

NOMESCO Finland

Guidance related to known health problem

24.1

17.3

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

4.3

17.3

151

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

42.2

17.3

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

17.3

329

1939

196

Kela drug reimbursment

Paricalcitol and cinacalcet

11.1

17.2

JFB30

NOMESCO Finland

Right hemicolectomy

6.3

17.1

KWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in urological surgery

17.4

16.9

B03XA01

ATC

erythropoietin; parenteral

5.6

16.9

WX892

NOMESCO Finland

Monitored bed care

1.9

16.8

254

1384

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

+∞

16.7

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

16.7

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

16.7

M907, C6488

ICD-10 Finland

+∞

16.7

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

16.7

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

4.2

16.6

148

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

170.7

16.5

C08CA02

ATC

felodipine; oral

1.7

16.4

367

2270

ZX112

NOMESCO Finland

Subcutaneous

5.6

16.3

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

16.2

162

745

E83.50

ICD-10 Finland

Hypercalcemia

4.9

16.1

107

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

30.2

16.1

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

3.2

16.0

266

XX9XW

NOMESCO Finland

9.0

15.9

WX290

NOMESCO Finland

Other blockade of nerve

1.4

15.8

979

7605

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

33.5

15.7

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

15.6

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

+∞

15.6

8120/3-C68.0

ICD-O-3

Transitional cell carcinoma, NOS, of urethra

+∞

15.6

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

15.6

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

15.6

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

15.6

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

15.6

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

5.2

15.6

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

85.4

15.6

L04AA06

ATC

mycophenolic acid; systemic

4.1

15.5

148

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

15.5

571

3999

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

160.6

15.5

V03AE02

ATC

sevelamer; oral

7.4

15.4

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

3.6

15.3

190

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.5

15.2

206

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

11.3

15.2

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

15.2

220

1180

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

45.2

15.1

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.7

15.0

357

2245

A10BH05

ATC

linagliptin; oral

2.0

14.9

197

1020

N03AX16

ATC

pregabalin; oral

1.5

14.8

652

4737

GDC00

NOMESCO Finland

Lobectomy of lung

16.5

14.7

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

14.7

282

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

14.6

U76

ICPC

Malignant neoplasm of bladder

+∞

14.6

8120/3-C68.8

ICD-O-3

Transitional cell carcinoma, NOS, of overlapping lesion of urinary organs

+∞

14.6

L02BX02

ATC

degarelix; parenteral

+∞

14.6

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

14.6

C79.0

ICD-10 Finland

Secondary malignant neoplasm of kidney and renal pelvis

+∞

14.6

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

14.6

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

14.6

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

14.6

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

14.6

KCC20

NOMESCO Finland

Cystoprostatourethrectomy

+∞

14.6

H02AB06

ATC

prednisolone; systemic

1.3

14.6

1373

11392

KKB10

NOMESCO Finland

Excision of retroperitoneal tumour

80.4

14.6

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

4.8

14.5

102

RJ128

NOMESCO Finland

10.1

14.4

KCW02

NOMESCO Finland

Lavation of bladder for coagulated blood

4.5

14.4

112

C08CA13

ATC

lercanidipine; oral

1.6

14.3

450

3039

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

11.4

14.2

ZXC20

NOMESCO Finland

Use of chemical agents

3.9

14.2

151

WX600

NOMESCO Finland

Single shot through catheter

8.6

14.2

L57.0

ICD-10 Finland

Actinic keratosis

1.8

14.1

241

1370

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

14.1

979

7726

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

15.8

13.9

GDB10

NOMESCO Finland

Wedge resection of lung

53.5

13.8

N99.0

ICD-10 Finland

Postprocedural renal failure

23.8

13.8

Y83.6

ICD-10 Finland

Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

20.1

13.8

B05DA

ATC

Isotonic solutions

5.3

13.7

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.0

13.6

262

XW000

NOMESCO Finland

Bone marrow biopsy

2.5

13.6

104

418

KBD00

NOMESCO Finland

Partial excision of ureter

75.4

13.6

L01EG02

ATC

everolimus; oral (mammalian target of rapamycin kinase inhibitors (mtor))

+∞

13.5

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

13.5

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

13.5

AA049

NOMESCO Finland

Radiotherapy of metasthasis in the brain

+∞

13.5

D41

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of urinary organs

+∞

13.5

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

13.5

JAH01

NOMESCO Finland

Laparoscopy

2.7

13.5

336

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

140.5

13.4

G04BE03

ATC

sildenafil; oral

7.0

13.3

WW200

SPAT

0.5

13.2

1744

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.7

13.2

307

1914

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

13.1

423

2867

KA3GB

NOMESCO Finland

Retrograde pyelography

16.7

13.0

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

8.8

13.0

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

9.3

12.9

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.0

12.9

157

789

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.4

12.9

112

483

J01CA04

ATC

amoxicillin; systemic

1.3

12.9

2287

20639

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

22.6

12.9

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

22.6

12.9

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.1

12.8

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.2

12.8

L02BG03

ATC

anastrozole; oral

50.2

12.8

TJF80

NOMESCO Finland

Ostomy education

8.1

12.8

A41.9

ICD-10 Finland

Sepsis, unspecified

2.2

12.8

123

559

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

7.2

12.7

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

32.1

12.6

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

12.5

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

12.5

NA049

NOMESCO Finland

Radiotherapy of methastasis in spine

+∞

12.5

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

12.5

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

12.5

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

12.5

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

12.5

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

12.5

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

12.5

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

11.0

12.5

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

9.3

12.4

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

9.3

12.4

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

130.4

12.4

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

130.4

12.4

X76

ICPC

Malignant neoplasm breast female

130.4

12.4

C67.4

ICD-10 Finland

Malignant neoplasm: Posterior wall of bladder

130.4

12.4

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

130.4

12.4

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

4.0

12.4

120

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

13.2

12.4

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.7

12.3

291

1822

N30.0

ICD-10 Finland

Acute cystitis

1.6

12.3

348

2282

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

12.3

220

1269

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

12.2

1270

10606

N05CF01

ATC

zopiclone; oral

1.3

12.2

976

7841

KAB00

NOMESCO Finland

Biopsy of kidney or pelvis of kidney

37.6

12.2

L02AE04

ATC

triptorelin; parenteral

37.6

12.2

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.0

12.1

118

N19

ICD-10 Finland

Unspecified kidney failure

2.1

12.1

139

680

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

12.1

218

1259

1530

FHL

Urethrocystoscopy

2.8

12.1

281

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.2

12.1

109

Z49.2

ICD-10 Finland

Other dialysis

4.9

12.0

PG1PT

NOMESCO Finland

Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified

6.2

11.9

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

7.5

11.9

P01AB01

ATC

metronidazole; oral, rectal

1.3

11.7

985

7965

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.0

11.7

217

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

11.7

112

506

N06DX01

ATC

memantine; oral

0.5

11.6

1751

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

4.3

11.6

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

4.6

11.5

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

11.5

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

11.5

1891C

ICD-9 Finland

Malignant neoplasm of kidney and other and unspecified urinary organs, Renal pelvis[NEOPLASMA MALIGNUM PELVIS RENIS,MUU/TARK MÄÄR SYÖPÄ]

+∞

11.5

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

11.5

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

11.5

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

11.5

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

11.5

1891X

ICD-9 Finland

Malignant neoplasm of kidney and other and unspecified urinary organs, Renal pelvis[NEOPLASMA MALIGNUM PELVIS RENIS,EI HIST VAHV]

+∞

11.5

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

11.5

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

11.5

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

11.5

8000/3-C65.9

ICD-O-3

Neoplasm, malignant of renal pelvis

+∞

11.5

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

11.5

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

11.5

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

11.5

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

11.5

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

+∞

11.5

KCC30

NOMESCO Finland

Cystectomy with excision of female internal genital organs

120.3

11.4

7323

FHL

Electrosection of TU bladder wall change

120.3

11.4

R84

ICPC

Malignant neoplasm bronchus/lung

120.3

11.4

E87.5

ICD-10 Finland

Hyperkalaemia

2.7

11.4

278

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

11.4

1280

10783

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.3

11.3

167

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

8.3

11.3

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

11.2

395

2728

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

7.3

11.2

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

11.1

329

2182

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

25.1

11.1

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

11.1

193

1103

ZXC50

NOMESCO Finland

Cryotherapy

2.8

11.0

256

N18

ICD-10 Finland

Chronic kidney disease

3.3

11.0

166

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.4

11.0

377

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.5

11.0

140

R82.8

ICD-10 Finland

Abnormal findings on cytological and histological examination of urine

13.9

10.9

WX002

NOMESCO Finland

Sedation and analgesia

1.4

10.9

553

4107

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

43.4

10.9

KED22

NOMESCO Finland

Transurethral resection of prostate

1.7

10.8

225

1362

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

6.1

10.7

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.1

10.7

192

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.5

10.6

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.1

10.5

116

560

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

10.5

101

458

KCB00

NOMESCO Finland

Biopsy of bladder

9.2

10.5

WF099

NOMESCO Finland

Other radiotherapy

14.2

10.5

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

3.8

10.4

115

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

110.3

10.4

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

110.3

10.4

U77

ICPC

Malignant neopl urinary tract other

110.3

10.4

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

110.3

10.4

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

110.3

10.4

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

+∞

10.4

8000/3-C68.9

ICD-O-3

Neoplasm, malignant of urinary system, NOS

+∞

10.4

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

10.4

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

10.4

8130/3-C65.9

ICD-O-3

Papillary urothelial carcinoma of renal pelvis

+∞

10.4

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

10.4

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

10.4

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

10.4

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

10.4

ZX022

NOMESCO Finland

LDR radiotherapy within tissue

+∞

10.4

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

10.4

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

10.4

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

10.4

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

10.4

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

10.4

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

10.4

KBV10

NOMESCO Finland

Removal of stent from ureter

5.4

10.4

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

3.9

10.4

106

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

3.8

10.3

111

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

12.0

10.3

B05DB

ATC

Hypertonic solutions

5.0

10.3

SPAT1254

SPAT

Administration of medicine

1.4

10.2

432

3102

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.0

10.1

120

596

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.1

10.1

177

TK820

NOMESCO Finland

Peritoneal dialysis

5.9

10.1

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.4

10.1

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

11.3

10.0

Q60.0

ICD-10 Finland

Renal agenesis, unilateral

40.2

10.0

J94.8

ICD-10 Finland

Other specified pleural conditions

3.0

9.8

181

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

9.8

797

6390

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

10.6

9.8

H02AB09

ATC

hydrocortisone; systemic

2.8

9.7

222

KBB00

NOMESCO Finland

Biopsy of ureter

55.1

9.6

PJD99

NOMESCO Finland

Excision of other lymph nodes

55.1

9.6

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

7.8

9.6

JLC30

NOMESCO Finland

Pancreatoduodenectomy

15.0

9.5

7124

FHL

Nephrectomy (simple

15.0

9.5

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

9.5

201

1221

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

5.4

9.5

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.7

9.5

105

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

4.2

9.4

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

30.1

9.4

ZX121

NOMESCO Finland

Central venous catheter

17.6

9.4

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

17.6

9.4

SPAT1262

SPAT

Handing over of treatment supplies

1.4

9.4

565

4317

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

9.4

KE002

NOMESCO Finland

Radical radiotherapy of prostata and seminal vesicles

+∞

9.4

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

+∞

9.4

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

9.4

PHN70

NOMESCO Finland

Plastic repair of inferior vena cava

+∞

9.4

L01CA04

ATC

vinorelbine; systemic

+∞

9.4

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

+∞

9.4

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

9.4

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

9.4

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

+∞

9.4

JL1AT

NOMESCO Finland

Biopsy of pancreas with ultrasound guidance

+∞

9.4

XX1XN

NOMESCO Finland

Other isotope examination

+∞

9.4

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

9.4

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

+∞

9.4

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

9.4

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

9.4

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

+∞

9.4

KB1DG

NOMESCO Finland

Very extensive MRI of urinary tract

21.7

9.3

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.5

9.3

1258

KA3EB

NOMESCO Finland

Antegrade pyelography

6.9

9.3

XF612

NOMESCO Finland

Measurement of central venous pressure

10.7

9.3

C09BA02

ATC

enalapril and diuretics; systemic

1.5

9.2

296

2001

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.4

9.2

GDA20

NOMESCO Finland

Excision of lesion of lung

13.7

9.2

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

7.7

9.1

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

6.2

9.1

PC5SC

NOMESCO Finland

Selective angiography of kidney artery with X-ray

11.5

9.1

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

36.8

9.0

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

9.0

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.7

8.9

217

E89.6

ICD-10 Finland

Postprocedural adrenocortical(-medullary) hypofunction

24.1

8.9

C09AA02

ATC

enalapril; systemic

1.3

8.9

698

5552

L02AE03

ATC

goserelin; implant

12.5

8.9

N06DA02

ATC

donepezil; oral

0.5

8.8

1466

KCW96

NOMESCO Finland

Other operations on bladder

4.9

8.8

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

8.6

8.8

105

Kela drug reimbursment

Adrenal cortical hypofunction

9.5

8.8

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

5.9

8.7

JFB43

NOMESCO Finland

Left hemicolectomy

5.9

8.7

J01MA14

ATC

moxifloxacin; systemic

1.6

8.7

238

1553

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

8.7

532

4071

C07AB07

ATC

bisoprolol; oral

1.2

8.7

1599

14152

ZX100

NOMESCO Finland

Oral

3.3

8.7

124

N04.1

ICD-10 Finland

Nephrotic syndrome, focal and segmental glomerular lesions

14.0

8.7

ZXC15

NOMESCO Finland

Use of photodynamic technique

4.2

8.7

S15

ICPC

Foreign body in skin

1.7

8.7

161

945

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

8.6

191

1176

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

5.2

8.6

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

8.5

269

1813

R60.0

ICD-10 Finland

Localized oedema

1.5

8.5

309

2148

TPX15

NOMESCO Finland

Removal of vascular injection port

9.0

8.5

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

3.8

8.5

K65.0

ICD-10 Finland

Acute peritonitis

3.3

8.5

121

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

8.5

138

777

KWA00

NOMESCO Finland

Repair of wound dehiscence in urological surgery

27.6

8.5

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

20.1

8.5

KDE20

NOMESCO Finland

Removal of foreign body from urethra

6.0

8.4

PC1CC

NOMESCO Finland

Very extensive angiography of aorta and abdominal arteries

7.3

8.4

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

90.2

8.4

L02BG06

ATC

exemestane; oral

90.2

8.4

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

4.7

8.4

H03AA01

ATC

levothyroxine sodium; systemic

1.3

8.4

566

4401

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.5

8.4

242

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.8

8.4

193

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

8.3

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

+∞

8.3

Q85.82

ICD-10 Finland

of Hipple-Lindau syndrome

+∞

8.3

C16.00

ICD-10 Finland

Cardia

+∞

8.3

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

8.3

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

8.3

9680/3-C64.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of kidney, NOS

+∞

8.3

Z08.2

ICD-10 Finland

Follow-up examination after chemotherapy for malignant neoplasm

+∞

8.3

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

8.3

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

8.3

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

8.3

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

8.3

1CD02

NOMESCO Finland

+∞

8.3

K62.7

ICD-10 Finland

Radiation proctitis

+∞

8.3

E0000UV

ATC

1.3

8.3

991

8330

KA1FN

NOMESCO Finland

Isotope renography

6.2

8.3

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

8.5

8.3

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

4.3

8.3

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

5.5

8.3

JAL30

NOMESCO Finland

Omentectomy

9.4

8.3

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

3.0

8.2

152

KBH20

NOMESCO Finland

Replantation of ureter

14.5

8.2

JN1CM

NOMESCO Finland

Upper part of abdomen extensive MRI examination with 3 Tesla magnet

14.5

8.2

M10.9

ICD-10 Finland

Gout, unspecified

1.6

8.2

235

1550

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.0

8.2

147

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

6.5

8.2

JFB00

NOMESCO Finland

Partial resection of small intestine

3.0

8.1

153

J01CA08

ATC

pivmecillinam; oral

1.3

8.1

798

6543

D77

ICPC

Malignant digestive neopl other/NOS

33.4

8.1

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

33.4

8.1

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

33.4

8.1

D41.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Urethra

33.4

8.1

XX9KE

NOMESCO Finland

Ultrasound examination with contrast

17.2

8.1

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

11.7

8.1

WX610

NOMESCO Finland

Patient controlled analgesia

6.8

8.0

HAB99

NOMESCO Finland

Other partial excision of mammary gland

4.8

8.0

D30.1

ICD-10 Finland

Benign neoplasm: Renal pelvis

22.1

8.0

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

22.1

8.0

N28.8

ICD-10 Finland

Other specified disorders of kidney and ureter

7.2

7.9

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.7

7.9

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

4.4

7.9

G04CB02

ATC

dutasteride; oral

1.5

7.9

247

1662

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

7.9

401

2976

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.9

7.8

N43.3

ICD-10 Finland

Hydrocele, unspecified

2.2

7.8

352

KEB00

NOMESCO Finland

Biopsy of prostate

3.7

7.8

R06.0

ICD-10 Finland

Dyspnoea

1.3

7.8

713

5785

KCD30

NOMESCO Finland

Destruction of tumour of bladder

45.1

7.7

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

45.1

7.7

N02AA03

ATC

hydromorphone; systemic, rectal

15.0

7.7

WX250

NOMESCO Finland

Intercostal blockade

15.0

7.7

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

2.9

7.7

151

N20.1

ICD-10 Finland

Calculus of ureter

1.8

7.7

121

673

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

7.4

7.7

212

Kela drug reimbursment

Gout

2.2

7.7

362

C09CA01

ATC

losartan; oral

1.3

7.6

743

6075

SPAT1263

SPAT

Sampling

1.2

7.6

1161

10017

KBV00

NOMESCO Finland

Insertion of stent into ureter

4.7

7.6

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.5

7.6

233

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

11.9

7.6

JFF23

NOMESCO Finland

Transversostomy

6.2

7.5

C07AB02

ATC

metoprolol; systemic

1.3

7.5

740

6064

Z93.3

ICD-10 Finland

Colostomy status

7.1

7.5

JFB46

NOMESCO Finland

Resection of sigmoid colon

3.2

7.5

112

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.6

7.4

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

80.2

7.4

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

80.2

7.4

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

6.5

7.4

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

2.5

7.4

212

A46

ICD-10 Finland

Erysipelas

1.4

7.4

427

3238

R11

ICD-10 Finland

Nausea and vomiting

1.6

7.3

186

1190

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

7.3

509

3970

U28

ICPC

Limited function/disability (U)

3.2

7.3

114

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

7.3

C68

ICD-10 Finland

Malignant neoplasm of other and unspecified urinary organs

+∞

7.3

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

7.3

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

7.3

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

7.3

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

+∞

7.3

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

7.3

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

+∞

7.3

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

7.3

1XC17

NOMESCO Finland

+∞

7.3

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

7.3

L01AX03

ATC

temozolomide; systemic

+∞

7.3

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

7.3

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

7.3

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

7.3

G04BE30

ATC

drugs used in erectile dysfunction - combinations

+∞

7.3

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

7.3

8070/3-C68.0

ICD-O-3

Squamous cell carcinoma, NOS, of urethra

+∞

7.3

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

+∞

7.3

KAC96

NOMESCO Finland

Other nephrectomy

+∞

7.3

JJB10

NOMESCO Finland

Atypcal resection of liver

+∞

7.3

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

7.3

C54.10

ICD-10 Finland

Malignant tumor of endometrium without histology

+∞

7.3

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

+∞

7.3

8480/3-C50.9

ICD-O-3

Mucinous adenocarcinoma of breast, NOS

+∞

7.3

XX6LT

NOMESCO Finland

Coagulation of tumour with radiological guidance

+∞

7.3

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

7.3

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

7.3

390

Kela drug reimbursment

Ibrutinib

+∞

7.3

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

+∞

7.3

5BX04

NOMESCO Finland

+∞

7.3

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

7.3

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

+∞

7.3

PHC70

NOMESCO Finland

Suture of inferior vena cava

+∞

7.3

M90.7

ICD-10 Finland

Fracture of bone in neoplastic disease

+∞

7.3

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

7.3

BAA60

NOMESCO Finland

Total thyroidectomy

2.9

7.3

146

K46.9

ICD-10 Finland

Unspecified abdominal hernia without obstruction or gangrene

4.0

7.2

A07AA02

ATC

nystatin; oral

1.6

7.2

161

996

R04.2

ICD-10 Finland

Haemoptysis

1.9

7.2

106

577

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

7.2

381

2845

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

7.2

496

3866

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

2.1

7.2

366

7321

FHL

TU biopsy, coagulation or laser

7.3

7.2

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

30.1

7.1

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

20.0

7.1

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

2.6

7.1

186

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

8.8

7.0

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

4.7

7.0

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.6

6.9

153

945

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

4.4

6.9

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

2.8

6.9

153

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

2.6

6.9

177

JN3BG

NOMESCO Finland

MRI examination of abdomen with high intensity magnet

13.8

6.9

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

4.8

6.8

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

8.3

6.8

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

8.3

6.8

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

10.9

6.8

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

6.1

6.8

SPAT1109

SPAT

Analgesia with portable analgesic pump

5.3

6.8

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

40.1

6.8

PC5NT

NOMESCO Finland

Endovascular embolisation for kidney bleeding with radiological guidance

40.1

6.8

XX1AD

NOMESCO Finland

Other CT-examination

40.1

6.8

KFC10

NOMESCO Finland

Bilateral orchiectomy

40.1

6.8

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.7

6.7

JKA20

NOMESCO Finland

Cholecystectomy

2.0

6.7

433

JG1CG

NOMESCO Finland

Extensive MRI of rectum

16.7

6.7

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

6.7

986

8446

DAB00

NOMESCO Finland

Excision of lesion of auricle

4.3

6.7

Z80.5

ICD-10 Finland

Family history of malignant neoplasm of urinary tract

22.5

6.7

N17.8

ICD-10 Finland

Other acute renal failure

2.8

6.7

145

C09DA01

ATC

losartan and diuretics; oral

1.4

6.7

311

2274

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.8

6.6

139

F03

ICD-10 Finland

Unspecified dementia

0.5

6.6

1142

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.9

6.6

443

DHB00

NOMESCO Finland

Excision of lesion of external nose

5.9

6.6

306

Kela drug reimbursment

Erythropoietin and darbepoetin

5.9

6.6

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

5.9

6.6

N28.9

ICD-10 Finland

Disorder of kidney and ureter, unspecified

5.9

6.6

J01MA01

ATC

ofloxacin; systemic

1.5

6.6

240

1673

EB1WA

NOMESCO Finland

4.6

6.6

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.2

6.6

GD2SN

NOMESCO Finland

Lung ventilation SPECT

3.7

6.5

ZQZ00

NOMESCO Finland

Treatment of several skin areas

8.7

6.5

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

6.5

808

6794

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.6

6.5

1571

RD210

NOMESCO Finland

2.7

6.5

148

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

6.4

167

1078

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

6.4

655

5377

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.5

6.4

837

WX1BG

NOMESCO Finland

Total body MRI with high intensity magnet

69.9

6.4

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

69.9

6.4

L04AX04

ATC

lenalidomide; oral

69.9

6.4

153

Kela drug reimbursment

Lenalidomid

69.9

6.4

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

2.7

6.4

143

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

7.4

6.4

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.4

6.4

211

TKE10

NOMESCO Finland

Puncture of prostate

14.3

6.4

H05BX02

ATC

paricalcitol; systemic

14.3

6.4

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

14.3

6.4

L04AD01

ATC

ciclosporin; systemic

2.5

6.4

178

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.4

6.4

212

E66.8

ICD-10 Finland

Other obesity

1.8

6.3

525

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.7

6.3

120

711

N13.1

ICD-10 Finland

Hydronephrosis with ureteral stricture, not elsewhere classified

6.5

6.3

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.9

6.3

410

U99

ICPC

Urinary disease other

3.6

6.3

J01FF01

ATC

clindamycin; systemic

1.3

6.3

689

5709

N03.1

ICD-10 Finland

Chronic nephritic syndrome, focal and segmental glomerular lesions

18.0

6.3

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

+∞

6.2

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

+∞

6.2

WE198

NOMESCO Finland

Palliative cystotatic therapy

+∞

6.2

KAD10

NOMESCO Finland

Heminephrectomy

+∞

6.2

8140/3-C16.9

ICD-O-3

Adenocarcinoma, NOS, of stomach, NOS

+∞

6.2

8318/3-C64.9

ICD-O-3

Renal cell carcinoma, sarcomatoid of kidney, NOS

+∞

6.2

1899X

ICD-9 Finland

Malignant neoplasm of kidney and other and unspecified urinary organs, Urinary organ, site unspecified[NEOPLASMA MAL ORG URIN NUD,EI HIST VAHV]

+∞

6.2

C50.30

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication

+∞

6.2

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

6.2

C16.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of stomach

+∞

6.2

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

6.2

C44.59

ICD-10 Finland

Malignant tumor of the skin on the trunk other or unspecified histology

+∞

6.2

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

6.2

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

+∞

6.2

1890C

ICD-9 Finland

Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,MUU/TARK MÄÄR SYÖPÄ]

+∞

6.2

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

+∞

6.2

19399

ICD-8 Finland

Malignant neoplasm of thyroid gland

+∞

6.2

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

6.2

8316/3-C64.9

ICD-O-3

Cyst-associated renal cell carcinoma of kidney, NOS

+∞

6.2

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

6.2

8890/3-C64.9

ICD-O-3

Leiomyosarcoma, NOS, of kidney, NOS

+∞

6.2

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

6.2

L01XE27

ATC

[U] ibrutinib; oral

+∞

6.2

L01CB01

ATC

etoposide; systemic

+∞

6.2

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

+∞

6.2

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

+∞

6.2

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

+∞

6.2

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

+∞

6.2

8070/3-C44.2

ICD-O-3

Squamous cell carcinoma, NOS, of external ear

+∞

6.2

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

+∞

6.2

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

6.2

L02BB01

ATC

flutamide; oral

+∞

6.2

2230A

ICD-9 Finland

Benign neoplasm of kidney and other urinary organs, Kidney, except pelvis

+∞

6.2

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

6.2

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

6.2

C44.20

ICD-10 Finland

Malignant tumor of the skin of the outer ear and of the outer ear canal without histology

+∞

6.2

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

6.2

8140/3-C16.0

ICD-O-3

Adenocarcinoma, NOS, of cardia, NOS

+∞

6.2

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

+∞

6.2

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

6.2

KBC00

NOMESCO Finland

Ureterectomy

+∞

6.2

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

6.2

323

Kela drug reimbursment

Sorafenib

+∞

6.2

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

+∞

6.2

HA1HA

NOMESCO Finland

Tomosynthesis mammography

26.7

6.2

7121

FHL

Removal of local change or renal resection (eg cyst)

26.7

6.2

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.6

6.2

138

858

A28

ICPC

Limited function/disability NOS

1.3

6.2

463

3647

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.2

6.2

273

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.9

6.2

464

A10AE04

ATC

insulin glargine; parenteral

1.4

6.2

280

2038

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

3.9

6.2

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

2.8

6.2

128

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

6.3

6.2

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

2.7

6.1

151

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.9

6.1

426

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.3

6.1

234

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.4

6.1

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

6.1

603

4931

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.1

6.1

301

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.1

6.1

289

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

6.1

640

5275

B82

ICPC

Anaemia other/unspecified

2.0

6.1

351

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

8.6

6.0

PJA10

NOMESCO Finland

Exploration of lymph nodes

4.9

6.0

GDA21

NOMESCO Finland

Thoracoscopic excision of lesion of lung

10.0

6.0

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.8

6.0

103

592

SPAT1255

SPAT

Intravenous administration of medicine

1.5

6.0

176

1169

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3044640) Blood type and Crossmatch panel - Blood

2207

10132

3.22

307.65

3.1

2.2

—

(4035726)

950

1022

11.39

307.65

1.4

1.2

—

(3049717) Cytology report of Urine Cyto stain

780

1359

6.68

307.65

4.3

1.8

—

(40768804) Tissue Pathology biopsy report

2319

10702

3.30

307.65

2.7

1.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2935

15295

3.44

307.65

5.2

3.7

—

(3037121) Protein [Mass/volume] in Urine

645

1239

5.87

307.65

2.9

2.8

g/l

0.3

1.22

425

451

(3024561) Albumin [Mass/volume] in Serum or Plasma

2798

15440

3.00

290.41

7.8

3.9

g/l

34.0

35.2

22.04

2637

14038

(3002582) Erythrocytes [#/volume] in Urine

2247

11179

2.93

279.74

5.5

3.1

e6/l

109.9

97.2

0.20

1892

8552

(3020779) Urea [Moles/volume] in Serum or Plasma

1083

3531

3.68

276.49

9.0

7.0

mmol/l

11.4

11.2

0.37

1020

3328

(3002256) Pathology report gross observation

901

2627

4.00

270.28

1.5

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

769

1999

4.40

269.55

8.0

9.8

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1289

4822

3.30

263.53

8.5

6.3

mmol/l

104.8

104.3

3.73

1271

4698

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1119

3840

3.51

262.85

4.3

2.7

u/l

234.2

240.6

0.84

1086

3550

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1273

4777

3.28

258.33

8.7

5.6

mmol/l

1.1

1.0

3.90

1198

4368

(3030467) Casts [#/volume] in Urine by Automated count

2078

10256

2.84

257.31

5.4

3.0

e6/l

0.3

0.5

1.84

1717

7689

(3000991) Gas panel - Venous blood

988

3172

3.68

256.61

9.4

7.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1728

7766

2.94

254.84

2.9

2.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1082

3705

3.49

254.26

7.6

g/l

119.1

122.5

6.77

1059

3559

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2952

17570

2.82

251.68

11.0

3.8

umol/l

10.7

12.5

11.15

2851

16396

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

748

2014

4.23

249.25

3.1

1.4

ug/l

16.8

10.1

0.41

601

1505

(3016502) Oxygen saturation in Arterial blood

1146

4148

3.33

245.53

7.3

7.0

96.7

95.0

20.75

1110

3984

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2844

16767

2.76

244.22

10.2

5.4

mmol/l

1.2

0.92

2678

14774

(36304419) Bacteria [Presence] in Urine

1979

9783

2.76

240.56

5.3

3.0

—

(3003396) Base excess in Arterial blood by calculation

1196

4552

3.18

234.47

7.3

6.8

mmol/l

-0.3

1.3

32.85

965

3494

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1199

4589

3.16

232.62

7.3

6.8

kpa

5.3

5.0

17.27

1157

4363

(3027801) Oxygen [Partial pressure] in Arterial blood

1198

4588

3.16

232.13

7.2

6.8

kpa

13.7

11.5

34.49

1154

4350

(3000850) Epithelial cells [#/volume] in Urine

1681

7783

2.80

230.11

3.9

2.5

e6/l

3.7

4.3

1.87

1528

6722

(3018095) Leukocytes [#/volume] in Urine

2345

12867

2.64

227.74

6.2

3.5

e6/l

89.6

105.9

0.44

1943

9175

(3031040) Bacteria [#/volume] in Urine by Automated count

3522

23632

2.95

227.14

7.0

4.5

e6/l

489.1

2059.7

2.33

391

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

705

1957

4.06

224.18

8.5

8.7

mmol/l

23.4

24.4

13.88

677

1767

(3023368) Bacteria identified in Blood by Culture

2029

10500

2.64

220.48

5.5

3.9

—

(3026782) Osmolality of Urine

1565

7216

2.75

213.14

4.3

2.7

mosm/kgh2o

543.3

558.5

2.29

1397

6016

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2953

18551

2.59

209.53

11.6

5.8

mmol/l

1.2

1.63

2500

15516

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3760

27241

2.89

188.63

13.7

5.4

u/l

84.3

77.0

16.27

3649

25105

(3013650) Neutrophils [#/volume] in Blood by Automated count

2946

19024

2.47

188.33

13.9

6.2

e9/l

4.4

0.11

2583

16226

(3026008) Bacteria identified in Urine by Culture

1991

10813

2.46

187.78

4.0

3.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1240

5389

2.77

185.92

4.8

2.6

mmol/l

0.8

2.93

1184

4903

(3014111) Lactate [Moles/volume] in Serum or Plasma

908

3364

3.11

182.22

7.8

6.3

mmol/l

1.2

1.4

13.32

883

3212

(3032080) INR in Blood by Coagulation assay

2590

15980

2.38

180.76

11.0

11.3

inr

1.2

1.4

8.95

717

4361

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1291

5839

2.67

177.86

5.0

2.8

e6/l

1.7

2.0

0.70

809

3234

(3013826) Glucose [Moles/volume] in Serum or Plasma

3213

22061

2.44

171.50

7.1

4.5

mmol/l

6.9

0.00

3112

20606

(3015377) Calcium [Moles/volume] in Serum or Plasma

2012

11370

2.34

168.86

6.4

2.1

mmol/l

2.4

2.3

3.03

1808

9372

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1334

6358

2.53

162.90

4.7

2.6

e6/l

1.0

1.1

0.54

849

3719

(3035637) Corticotropin [Mass/volume] in Plasma

232

313

7.74

162.84

1.5

1.4

—

(3018418) pH of Serum or Plasma

1882

10624

2.29

155.09

7.4

3.3

7.4

7.91

414

1870

(3033658) Prothrombin time (PT) actual/Normal

1597

8417

2.36

154.66

5.5

3.6

89.7

83.9

14.66

1569

8193

(3037467) Urinalysis macro (dipstick) panel - Urine

3408

24917

2.33

143.41

6.5

4.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

317

710

4.71

131.45

2.9

1.8

u/ml

9124.0

120.7

0.58

274

556

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1183

6025

2.29

119.17

2.2

1.9

30.2

30.1

0.03

1169

5833

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1840

11379

2.01

110.01

4.1

2.3

u/l

67.6

60.2

1.42

1739

10395

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

700

2920

2.64

108.51

5.9

3.9

ng/l

132.6

98.5

8.67

614

2451

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1229

6577

2.18

108.15

5.6

2.2

mmol/l

2.5

2.4

18.67

1109

5584

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

404

1282

3.35

102.29

3.0

3.1

u/ml

0.4

0.3

0.70

195

748

(42870588) Differential panel, method unspecified - Blood

1844

11716

1.94

99.35

6.8

5.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1066

5569

2.18

98.50

3.8

2.6

g/l

2.1

2.3

15.48

1001

5097

(3036481) Cortisol [Moles/volume] in Serum or Plasma

660

2804

2.57

97.95

5.1

1.8

nmol/l

397.2

366.0

3.47

632

2516

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1009

5205

2.19

95.97

3.9

2.7

20.0

22.5

7.48

870

4328

(3022096) Basophils/100 leukocytes in Blood

2266

15548

1.88

95.26

7.0

5.6

0.6

0.7

3.48

2144

14274

(3019069) Monocytes/100 leukocytes in Blood

2321

16065

1.88

94.75

7.3

5.9

8.8

8.9

0.69

2195

14778

(3022948) Iron [Moles/volume] in Serum or Plasma

1116

6022

2.12

94.36

3.7

2.6

umol/l

10.7

12.7

18.42

1046

5494

(3006504) Eosinophils/100 leukocytes in Blood

2302

15984

1.86

92.14

7.0

5.6

2.9

3.0

1.68

2173

14642

(3002030) Lymphocytes/100 leukocytes in Blood

2347

16405

1.86

91.88

7.1

5.7

24.5

26.7

15.96

2207

14995

(3001604) Monocytes [#/volume] in Blood

2421

17197

1.84

88.90

6.7

5.3

e9/l

0.6

1.84

2065

14627

(3006315) Basophils [#/volume] in Blood

2432

17320

1.84

88.35

6.8

5.3

e9/l

0.0

0.86

2080

14762

(3018010) Neutrophils/100 leukocytes in Blood

2306

16225

1.83

86.51

6.9

5.5

60.1

58.2

10.91

2177

14926

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

627

2749

2.48

86.43

2.0

g/l

0.2

3.54

581

2473

(3013115) Eosinophils [#/volume] in Blood

2485

17890

1.82

86.37

7.0

5.5

e9/l

0.2

0.62

2149

15449

(3019198) Lymphocytes [#/volume] in Blood

2459

17656

1.82

86.13

6.8

5.4

e9/l

1.8

0.23

2130

15290

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

291

877

3.47

79.57

4.7

3.2

mg/l

1.9

1.7

1.93

267

772

(3003694) ABO and Rh group [Type] in Blood

1363

8372

1.88

77.16

1.4

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

192

440

4.51

76.99

1.3

—

(40758558) Short blood count panel - Blood

1318

8029

1.89

76.42

10.5

4.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1611

10533

1.80

73.87

4.5

2.6

u/l

32.4

35.9

1.05

1545

9866

(3002032) Base excess in Venous blood by calculation

770

3936

2.14

73.06

6.2

3.7

mmol/l

1.2

1.9

5.08

627

3180

(3021447) Carbon dioxide [Partial pressure] in Venous blood

769

3950

2.13

71.96

6.1

3.6

kpa

5.8

0.01

743

3818

(3012544) pH of Venous blood

788

4097

2.11

71.39

6.0

3.7

7.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

458

1893

2.57

70.92

7.0

4.0

mmol/l

23.7

24.1

2.05

421

1665

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

128

226

5.79

69.25

2.1

1.2

ug/l

20.2

19.6

0.06

121

218

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1078

6415

1.88

65.73

1.9

1.8

—

(3009261) Glucose [Presence] in Urine by Test strip

2380

17852

1.67

63.53

5.3

3.8

estimate

0.0

0.01

560

2886

(3035350) Ketones [Presence] in Urine by Test strip

2355

17648

1.67

62.82

5.2

3.7

estimate

0.0

0.50

556

2973

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

596

2932

2.18

61.66

3.0

2.2

u/l

58.2

55.6

0.03

531

2457

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

687

3577

2.08

61.30

3.2

2.2

umol/l

8.2

8.4

0.12

618

3060

(3009214) Lutropin [Units/volume] in Serum or Plasma

209

601

3.59

61.26

1.5

1.4

u/l

16.2

8.1

6.76

158

486

(3021601) Nitrite [Presence] in Urine by Test strip

2346

17644

1.66

61.05

7.0

5.0

estimate

0.0

0.00

563

3022

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

533

2521

2.26

60.70

1.7

1.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

649

3324

2.10

60.45

3.0

1.6

g/l

65.6

66.6

2.74

596

2930

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

21.63

60.40

7.5

1.2

—

(40768800) Prostate Pathology biopsy report

138

331

4.26

52.16

1.2

1.1

—

(1616796) Gas panel - Central venous blood

244

852

2.97

51.97

4.4

3.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

550

2800

2.09

51.60

2.0

1.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

794

4643

1.85

49.62

2.6

2.1

1.8

1.7

0.25

719

4024

(3017143) Hepatitis C virus Ab [Presence] in Serum

516

2612

2.10

49.03

2.0

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1481

10350

1.63

48.47

3.6

2.6

umol/l

3330.7

6232.3

1.97

1280

8741

(3009343) pH of Capillary blood

512

2626

2.07

46.88

4.9

3.8

7.4

1.90

312

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

500

2545

2.08

46.72

4.8

3.8

mmol/l

1.2

1.8

2.76

357

1820

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

517

2665

2.06

46.69

4.9

3.8

kpa

5.1

0.09

481

2444

(3019060) Gas panel - Arterial blood

539

2823

2.03

46.58

4.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

674

3820

1.89

46.20

4.4

3.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

760

4482

1.83

45.91

1.8

1.7

—

(3021589) Normoblasts [#/volume] in Blood

2011

15295

1.55

44.84

16.0

8.8

e9/l

0.0

1.30

1623

12425

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1857

13895

1.56

44.45

3.7

2.8

ug/l

209.3

145.9

12.25

1689

12590

(3042936) Bacteria identified in Isolate by Culture

837

5126

1.77

44.41

2.2

2.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1393

9772

1.60

44.00

2.4

2.3

mg/l

3.3

3.0

4.19

1191

8237

(3013707) Erythrocyte sedimentation rate by Westergren method

3179

26799

1.57

44.00

4.7

4.1

mm/h

18.5

12.7

41.40

2929

24487

(3018572) Chloride [Moles/volume] in Blood

234

874

2.77

43.97

6.2

7.0

mmol/l

105.9

104.9

3.48

215

781

(3039000) Anion gap in Blood

234

874

2.77

43.97

6.2

7.0

mmol/l

11.2

11.3

0.24

215

781

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

753

4484

1.81

43.89

1.8

1.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

161

493

3.35

42.79

5.0

5.4

iu/ml

756.5

815.9

0.04

(3047181) Lactate [Moles/volume] in Blood

291

1228

2.46

42.63

5.6

6.2

mmol/l

1.2

1.3

1.89

264

1086

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

147

426

3.53

42.57

2.6

1.8

u/ml

52.1

360.2

0.65

132

386

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

548

2975

1.95

42.56

7.0

3.1

mmol/l

1.2

0.11

508

2521

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

390

1893

2.16

41.09

1.7

1.5

g/l

1.9

1.5

6.19

328

1623

(3023520) Reticulocytes [#/volume] in Blood

611

3476

1.87

41.09

2.8

2.2

e9/l

67.0

68.1

0.31

454

2673

(3008152) Bicarbonate [Moles/volume] in Arterial blood

507

2713

1.97

40.99

6.8

6.9

mmol/l

24.2

24.5

1.20

482

2516

(3021879) Hepatitis B virus core Ab [Presence] in Serum

341

1580

2.25

40.31

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

157

5.23

39.65

1.3

u/l

34.5

31.5

0.26

112

(40768795) Lymph node Pathology biopsy report

7.91

39.57

1.2

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1276

8979

1.58

38.86

5.1

3.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

153

482

3.25

38.85

1.5

g/l

32.6

28.8

3.20

137

421

(3023323) Follitropin [Units/volume] in Serum or Plasma

140

423

3.38

38.02

1.6

1.3

iu/l

32.1

28.0

0.60

102

360

(3023199) Leukocytes [#/volume] in Pleural fluid

141

430

3.35

37.73

1.5

e6/l

1374.4

2372.4

0.94

310

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

215

834

2.65

37.50

2.1

2.3

g/l

3.9

3.6

1.84

207

786

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

134

401

3.41

36.95

1.5

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

579

3351

1.83

36.61

2.0

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

333

1589

2.18

36.55

2.0

1.8

ug/l

1.8

0.01

295

1367

(3012441) Differential panel - Pleural fluid

124

358

3.53

36.14

1.4

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

141

444

3.24

35.84

1.5

1.3

nmol/l

0.2

0.5

1.06

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

141

444

3.24

35.84

1.5

1.3

nmol/l

0.7

3.0

0.48

136

430

(40768806) Pleura Pathology biopsy report

117

330

3.61

35.32

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

130

393

3.37

35.29

1.4

1.3

nmol/l

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3941

35592

1.66

34.94

27.4

14.3

mg/l

35.9

25.4

53.32

3659

28166

(3024354) Oxygen [Partial pressure] in Venous blood

569

3321

1.81

34.91

4.5

3.1

kpa

4.8

4.5

1.71

544

3196

(3012501) Base excess in Blood by calculation

209

836

2.57

34.25

5.0

4.5

mmol/l

2.4

2.6

0.40

140

557

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

9.82

33.86

10.2

1.5

u/l

72.0

40.1

0.93

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

112

318

3.58

33.49

1.3

u/l

857.7

291.2

0.99

107

299

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

187

4.45

33.14

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

126

389

3.30

33.09

1.4

1.5

e6/l

73075.0

68125.2

0.04

224

(40761536) Microorganisms panel - Urine sediment

490

2782

1.85

32.80

5.8

4.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

187

724

2.65

32.74

3.9

1.5

u/ml

49.1

27.5

1.41

175

688

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

165

615

2.74

31.13

4.7

3.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

184

727

2.59

30.93

1.4

1.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

220

947

2.39

30.79

3.4

3.3

kpa

8.3

8.0

1.74

207

877

(3022313) Gas panel - Capillary blood

364

1916

1.98

30.59

5.0

4.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1748

13652

1.45

30.49

5.8

4.0

—

(3021901) Oxygen saturation in Capillary blood

189

767

2.53

30.06

3.5

2.8

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

6.20

30.03

6.6

1.1

u/ml

26.2

68.1

0.99

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

8.36

29.97

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

265

1254

2.18

29.64

2.6

1.5

ratio

1.5

2.5

0.87

110

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

343

1796

1.98

29.24

5.4

4.9

1.7

1.6

0.41

322

1685

(3007930) Methemoglobin/Hemoglobin.total in Blood

338

1763

1.99

29.13

5.4

4.9

0.9

2.94

317

1655

(3010421) pH of Blood

222

987

2.31

28.86

5.1

4.4

7.4

3.29

208

815

(3004588) Protein electrophoresis panel - Serum or Plasma

487

2872

1.78

28.60

2.2

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

423

2398

1.84

28.31

1.9

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

268

1299

2.13

28.19

2.7

1.5

mg/l

60.6

50.2

1.07

220

1037

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

267

1294

2.13

28.09

2.7

1.5

mg/l

73.6

41.6

0.97

218

1028

(40767503) Oxygen content in Capillary blood by calculation

193

818

2.42

27.97

3.2

2.5

16.3

0.08

116

443

(3045788) Cell count panel - Pleural fluid

107

332

3.27

27.91

1.5

1.6

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

131

4.78

27.54

2.4

2.1

18.9

15.1

0.46

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

235

1093

2.21

27.43

1.3

1.2

—

(40768446) Kidney Pathology biopsy report

133

4.71

27.05

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

126

4.81

26.86

2.3

2.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

194

841

2.36

26.74

2.1

88.7

89.1

0.10

187

798

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

182

767

2.43

26.71

2.1

2.3

219.1

196.5

2.54

174

729

(3009508) Creatinine [Moles/volume] in Urine

1692

13377

1.41

26.57

3.6

3.2

mmol/l

7.1

7.6

5.27

1397

11118

(3052851) Hemolysis interference index of Serum or Plasma

227

1055

2.21

26.54

4.3

3.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

235

3.67

26.50

1.2

1.3

u/l

15.1

11.0

0.67

207

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

402

2309

1.81

25.71

1.5

—

(3011412) CD3 cells [#/volume] in Blood

181

4.02

25.68

2.3

1.9

e9/l

1.0

0.25

105

(40768793) Breast Pathology biopsy report

151

4.28

24.83

1.3

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

6.02

24.63

2.0

2.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

317

3.17

24.56

1.4

mmol/l

6.2

6.7

0.70

285

(3015235) Bicarbonate [Moles/volume] in Capillary blood

226

1083

2.14

24.47

3.7

3.1

mmol/l

23.8

24.8

2.66

201

956

(3029937) Albumin [Presence] in Urine by Test strip

1281

9766

1.43

24.18

5.8

4.1

estimate

0.0

0.40

503

2910

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

6.44

23.88

1.9

2.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

479

2957

1.69

23.72

4.0

2.4

ml/min/173m2

48.3

62.2

21.44

290

1144

(3012516) Albumin [Mass/volume] in Urine

1644

13123

1.39

23.67

3.7

3.2

mg/l

497.7

296.7

1.08

1138

8534

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1024

7539

1.46

23.18

1.7

mg/l

1.7

1.3

2.70

842

5810

(3007853) Bacteria identified in Skin by Aerobe culture

636

4239

1.58

23.11

2.0

1.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

304

1654

1.90

23.07

5.5

4.3

mmol/l

24.2

24.8

2.09

286

1506

(3020682) Albumin/Creatinine [Ratio] in Urine

1721

13887

1.38

23.02

4.5

4.0

mg/mmol

22.7

9.0

12.08

1175

8941

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

297

1611

1.90

22.75

4.3

2.9

pmol/l

4.2

4.4

1.97

266

1389

(3036489) Thrombin time

225

1123

2.05

21.90

1.9

22.5

21.4

1.35

205

995

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

179

819

2.23

21.77

1.4

1.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1067

8006

1.43

21.60

4.7

4.2

ng/l

1206.6

545.5

0.38

935

6810

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

133

537

2.52

21.45

1.3

1.4

—

(3024928) Oxygen saturation in Venous blood

187

877

2.18

21.41

3.7

3.0

—

(40768441) Liver Pathology biopsy report

126

4.32

21.29

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

247

1290

1.97

21.17

2.5

2.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1907

15787

1.35

21.11

4.7

4.0

ng/l

72.7

78.7

0.08

1562

11915

(40760888) Immunoglobulin light chains.free panel - Serum

198

958

2.11

20.94

2.7

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

210

1043

2.06

20.72

1.9

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

167

760

2.24

20.59

1.3

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

163

736

2.26

20.48

1.3

1.4

—

(3037756) Immunofixation for Serum or Plasma

169

782

2.20

20.02

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1758

14466

1.34

19.90

2.6

2.2

nmol/l

79.8

78.6

0.98

1579

12531

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

120

484

2.52

19.43

6.0

6.5

mg/l

12.2

12.0

0.16

109

433

(3044889) 12 lead EKG panel

2937

26097

1.33

19.24

4.9

4.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1134

8748

1.39

19.23

4.8

3.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

124

516

2.44

18.79

1.9

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

114

457

2.53

18.71

1.9

1.5

u/ml

108.5

124.6

0.51

(3051651) Icteric interference index of Serum or Plasma

176

3.56

18.68

5.2

4.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

423

2685

1.63

18.67

4.7

3.2

g/l

118.9

130.4

18.59

417

2613

(3017181) Myelocytes/100 leukocytes in Blood

437

2803

1.62

18.49

4.0

3.7

0.8

0.13

165

628

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1608

13165

1.34

18.46

3.2

ng/l

2467.1

1673.2

5.15

1447

11356

(40761535) Cells panel - Urine sediment

512

3412

1.56

18.41

4.7

3.3

—

(3011985) Renin [Units/volume] in Plasma

116

473

2.49

18.37

1.6

1.3

mu/l

48.7

67.0

0.54

102

417

(40760892) CBC W Ordered Manual Differential panel - Blood

926

6959

1.41

18.17

5.0

4.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

121

4.08

17.98

26.4

24.0

ug/l

87.3

115.6

3.14

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

143

655

2.22

17.41

1.4

1.8

iu/l

2.3

4.6

5.04

194

(3019225) pH of Specimen

554

3811

1.51

17.18

7.6

3.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2457

21517

1.30

16.70

3.5

3.0

u/l

63.8

50.6

6.96

2268

19506

(3002385) Erythrocyte distribution width [Ratio]

3152

28540

1.32

16.65

36.3

17.0

14.3

13.7

58.76

3095

27738

(40765089) Chromosome analysis panel - Blood by G-banded

8.18

16.63

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

358

2.63

16.62

1.4

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

376

2.59

16.57

1.6

1.2

—

(3022145) Colonoscopy Study observation

513

3501

1.52

16.49

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

181

927

1.99

16.45

2.9

2.2

g/l

127.5

130.6

0.87

144

686

(3004809) Band form neutrophils/100 leukocytes in Blood

111

468

2.40

16.39

3.5

2.9

1.2

1.4

0.45

350

(3013512) EKG study

1433

11703

1.32

16.25

4.9

4.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

275

1624

1.74

15.93

2.0

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

275

1626

1.73

15.86

2.0

1.4

g/l

7.7

7.5

1.27

201

1172

(3002179) Metamyelocytes/100 leukocytes in Blood

396

2576

1.59

15.75

3.9

3.6

0.6

0.5

0.41

114

473

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

274

1622

1.73

15.73

2.0

1.4

g/l

3.9

0.22

196

1129

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

256

1491

1.76

15.57

2.0

1.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

236

1347

1.79

15.38

2.2

1.5

g/l

1.3

0.5

1.62

205

1130

(3021440) Promyelocytes/100 leukocytes in Blood

409

2698

1.57

15.31

4.1

3.7

0.1

0.31

154

588

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

387

2.48

15.15

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

257

1515

1.74

14.98

2.0

1.4

g/l

10.7

10.4

0.41

212

1241

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

316

1973

1.64

14.86

3.8

2.6

0.6

0.7

0.52

309

1885

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

257

1520

1.73

14.81

2.1

1.4

g/l

3.3

3.0

3.86

199

1152

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

107

467

2.32

14.66

1.3

1.4

—

(3035880) pH of Pleural fluid

196

3.09

14.54

1.4

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

348

2.53

14.43

3.7

3.0

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

342

2195

1.60

14.38

5.0

3.2

mmol/l

24.4

25.2

4.59

332

2116

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

267

1612

1.70

14.28

2.1

1.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

264

1598

1.69

13.99

1.2

iu/ml

152.6

124.2

0.45

573

(3019550) Sodium [Moles/volume] in Serum or Plasma

4009

37900

1.39

13.95

35.2

17.5

mmol/l

139.0

139.8

60.44

3941

36803

(3026250) Tacrolimus [Mass/volume] in Blood

117

3.70

13.86

29.8

36.0

ug/l

6.3

7.4

2.80

108

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

125

596

2.13

13.84

1.3

1.4

—

(3025159) Blasts/100 leukocytes in Blood

385

2565

1.55

13.77

4.2

3.8

0.1

0.4

0.49

133

520

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

102

449

2.30

13.73

1.3

pmol/l

243.6

274.1

0.67

338

(3021387) Prolactin [Units/volume] in Serum or Plasma

120

565

2.15

13.72

1.6

1.8

mu/l

326.2

294.8

0.64

114

521

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

5.71

13.66

1.1

pmol/l

6.5

3.8

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

4.11

13.45

1.2

ug/l

293.4

96.7

0.45

(3023103) Potassium [Moles/volume] in Serum or Plasma

4010

37986

1.38

13.14

35.6

17.6

mmol/l

4.1

4.0

61.79

3938

36827

(3021960) Folate [Moles/volume] in Serum or Plasma

1193

9735

1.30

13.05

1.7

1.6

nmol/l

18.7

20.2

2.62

1056

8211

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

123

597

2.09

13.02

3.5

60.1

58.7

0.59

123

597

(3023183) Ammonium ion [Moles/volume] in Plasma

150

786

1.94

12.83

1.7

2.5

umol/l

27.7

35.2

3.66

108

665

(3025315) Body weight

6.69

12.74

5.9

4.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

110

3.66

12.72

2.5

2.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

192

1092

1.79

12.70

1.9

1.5

g/l

0.0

0.00

181

986

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3582

33445

1.30

12.52

30.3

13.2

ml/min/173m2

62.0

74.8

191.14

3270

26969

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

101

461

2.22

12.51

1.2

1.3

—

(40761511) CBC panel - Blood by Automated count

3887

36707

1.34

12.49

27.5

14.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

194

1114

1.77

12.43

1.9

1.5

g/l

0.0

0.00

181

991

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

205

1197

1.75

12.40

1.9

1.5

g/l

0.0

0.62

191

1073

(3045142) Bone marrow Pathology biopsy report

266

2.62

12.39

1.3

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

3.76

12.25

1.3

1.4

mmol/l

2.4

3.2

1.02

(3016750) Collection duration of Urine

262

2.62

12.23

1.9

2.0

min

500.9

494.5

0.22

197

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1504

12733

1.27

12.10

2.2

u/l

187.2

237.6

1.58

1409

11845

(40768797) Stomach Pathology biopsy report

642

4830

1.38

12.10

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

102

477

2.16

11.92

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

213

1277

1.70

11.73

1.9

1.4

g/l

36.3

37.6

2.18

187

1054

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

109

528

2.09

11.64

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

334

2241

1.53

11.56

2.6

2.2

g/l

10.6

10.9

0.54

306

2047

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

220

2.70

11.34

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

333

2.36

11.33

3.9

3.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

241

1507

1.63

11.30

2.5

2.3

ug/l

439.8

671.5

0.76

234

1426

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.92

11.19

4.5

4.8

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

171

977

1.78

11.18

1.4

ug/g

242.3

282.7

1.93

109

588

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

281

2.48

11.11

1.2

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

102

497

2.08

10.76

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

367

2549

1.48

10.75

2.2

nmol/l

11.4

14.8

10.06

306

2215

(3051611) Lipemic interference index of Serum or Plasma

354

2.28

10.72

4.9

3.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

144

3.07

10.72

2.3

1.6

e6/l

652.9

712.9

0.15

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

135

728

1.88

10.66

1.4

1.6

—

(4281824)

156

2.97

10.55

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

138

755

1.85

10.42

1.6

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

248

2.52

10.39

1.2

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

164

2.88

10.26

2.1

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2868

26360

1.23

10.06

6.0

3.6

pmol/l

15.2

15.0

3.56

2613

23463

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

4.80

10.00

1.2

u/l

1643.5

802.0

0.20

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

20.05

9.79

1.2

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1990

17730

1.21

9.23

2.6

2.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

492

1.99

9.23

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

203

2.58

9.20

2.0

1.9

u/field

3.6

2.6

0.27

138

(3043409) Potassium [Moles/volume] in Arterial blood

206

1308

1.60

9.13

4.6

4.3

mmol/l

4.0

3.9

3.06

194

1229

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.60

9.09

1.6

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

315

2.24

9.08

1.3

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

188

1170

1.63

9.05

2.7

2.3

ug/min

194.5

120.1

1.17

118

688

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

229

2.46

9.01

1.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1915

17027

1.21

9.00

2.1

pmol/l

93.5

93.0

0.18

1102

8912

(3004775) Volume in Urine collected for unspecified duration

389

2.10

8.94

2.0

2.3

721.8

615.8

1.68

259

(3003181) Sodium [Moles/volume] in Urine

122

682

1.81

8.67

1.4

1.3

mmol/l

53.3

63.4

2.79

100

539

(3022217) INR in Platelet poor plasma by Coagulation assay

755

6088

1.29

8.64

27.9

30.1

inr

1.5

0.19

103

798

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

456

1.99

8.61

1.3

u/ml

279.6

278.7

0.01

279

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

4.39

8.60

1.6

1.1

ug/l

2.2

3.0

0.37

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

144

848

1.72

8.56

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

144

848

1.72

8.56

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

286

2.25

8.47

1.3

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

224

2.43

8.45

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

189

2.56

8.38

2.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

314

2.18

8.32

1.2

1.1

u/l

72.7

58.3

0.44

201

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

130

750

1.75

8.32

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

191

2.53

8.21

1.3

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

129

2.88

8.15

2.5

1.6

e6/l

477.6

447.6

0.17

116

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

192

2.52

8.13

1.3

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

108

3.07

8.11

2.3

2.7

—

(3045414) Leukocytes [Presence] in Urine

242

1640

1.50

8.05

2.3

1.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

116

654

1.79

8.04

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

114

3.00

8.02

2.8

2.2

27.9

43.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

259

1783

1.48

7.98

2.1

1.4

g/l

1.7

1.1

1.47

237

1605

(3020891) Body temperature

252

1726

1.49

7.96

5.9

4.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

159

2.66

7.95

1.3

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

159

2.66

7.95

1.3

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

183

2.53

7.89

1.3

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

128

2.83

7.67

1.5

1.4

62.2

64.3

0.12

103

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.35

7.64

1.2

pmol/l

385.4

252.5

0.60

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

4.51

7.64

1.1

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

123

2.86

7.62

2.6

1.6

e9/l

0.3

0.2

0.60

115

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

117

673

1.76

7.60

1.6

1.2

u/l

53.8

29.1

0.63

103

574

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3967

38110

1.26

7.50

37.3

16.6

umol/l

111.8

83.7

106.43

3967

38094

(3036603) Volume of Urine

200

2.41

7.48

1.5

1.4

1738.1

1976.4

0.50

(3042010) Triglyceride [Moles/volume] in Pleural fluid

4.01

7.34

1.3

1.2

mmol/l

0.7

2.7

0.65

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

227

2.31

7.32

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

190

2.44

7.32

1.6

1.4

u/l

4.2

5.8

0.34

(3018834) Bilirubin.total [Presence] in Urine by Test strip

15.75

7.22

12.6

1.1

estimate

0.0

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

248

1730

1.46

7.17

1.7

1.5

u/ml

25.0

18.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

316

2.07

7.04

3.4

2.6

59.4

60.3

0.10

201

(3042631) Mycobacterium sp identified in Specimen

506

1.83

6.97

2.0

3.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

499

1.84

6.96

1.5

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

4.58

6.92

3.4

1.9

e6/l

205.0

178.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

202

2.34

6.87

2.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

3289

31095

1.19

6.85

31.7

15.7

37.5

39.4

19.36

2113

19758

(3042733) HLA Ab [Presence] in Serum

2.97

6.79

6.5

5.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

161

2.50

6.74

1.1

—

(3047189) Immunofixation for 24 hour Urine

150

2.55

6.67

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

218

2.26

6.63

1.0

1.2

—

(3017732) Neutrophils [#/volume] in Blood

313

2330

1.37

6.28

4.1

3.2

e9/l

4.5

4.2

0.93

239

1656

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

258

2.11

6.16

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

258

2.11

6.16

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

258

2.11

6.16

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

497

1.79

6.16

1.3

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

195

2.27

6.04

1.1

—

(3022621) pH of Urine by Test strip

332

2510

1.35

6.04

3.8

3.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

336

1.95

6.00

2.5

2.1

u/field

3.3

1.7

1.14

121

(44790048)

359

1.91

5.90

1.6

1.4

—

(44790049)

359

1.91

5.90

1.6

1.4

—

(44790047)

359

1.91

5.90

1.6

1.4

—

(44806118)

359

1.91

5.90

1.6

1.4

—

(3025941) Bacteria identified in Stool by Culture

241

1736

1.41

5.90

1.3

—

(3004451) EKG impression Narrative

217

2.18

5.86

1.4

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3938

38024

1.22

5.77

17.0

9.4

u/l

27.0

25.9

0.43

3810

36208

(3024471) HLA-A [Type]

2.87

5.77

1.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

164

2.33

5.57

1.2

u/l

38.0

20.4

1.11

136

(3024522) Salmonella sp identified in Specimen by Organism specific culture

411

1.81

5.52

1.5

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

411

1.81

5.52

1.4

1.3

—

(3024932) HLA-DR beta [Type]

2.82

5.40

1.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

422

1.79

5.37

1.5

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

130

2.47

5.36

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

130

2.47

5.36

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

130

2.47

5.36

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

130

2.47

5.36

1.2

—

(3019150) Specific gravity of Urine by Refractometry

957

8299

1.19

5.35

6.0

4.2

kg/l

1.0

0.24

172

1249

(21494755) Public health laboratory ask at order entry panel

113

1749

0.64

5.33

1.3

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

5.21

1.0

0.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

125

812

1.55

5.19

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

405

1.79

5.17

1.5

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

406

1.79

5.13

1.5

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

158

2.29

5.11

1.4

nmol/l

0.2

0.3

0.18

125

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1291

0.59

5.10

1.8

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

408

1.78

5.06

1.5

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

128

2.43

5.03

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

461

1.73

5.02

1.1

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

166

2.24

4.99

1.1

—

(1761868) Lipid panel - Serum or Plasma

956

10898

0.85

4.98

3.4

3.3

—

(3008295) Osmolality of Serum or Plasma

346

1.83

4.91

1.3

1.4

mosm/kgh2o

275.7

278.6

0.32

258

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1975

18214

1.15

4.89

5.2

4.0

ug/l

3.3

2.4

1.51

1734

16311

(3000919) Neutrophils/100 leukocytes in Pleural fluid

100

2.61

4.88

1.7

1.4

23.4

22.6

0.05

(3001893) Eosinophils/100 leukocytes in Pleural fluid

106

2.56

4.87

1.7

1.5

1.0

2.3

1.55

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

486

3983

1.25

4.79

2.9

3.2

ng/l

318.3

233.3

1.95

454

3662

(40765096) Chromosome analysis panel by Banding

3.28

4.74

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

238

1.98

4.68

2.7

2.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

178

2.14

4.64

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3410

32694

1.16

4.64

6.7

4.5

mu/l

2.1

0.56

3129

29281

(3020393) Adenovirus Ag [Presence] in Stool

4.15

4.62

1.0

1.8

—

(3045424) Erythrocytes [Presence] in Urine

596

1.61

4.61

1.6

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.76

4.60

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

436

1.71

4.57

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

2.87

4.49

1.0

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

186

1351

1.39

4.43

1.5

1.6

titre

117.8

278.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

128

868

1.49

4.41

1.4

1.9

mg/l

12.6

11.6

0.66

116

797

(3017704) Immunofixation for Urine

230

1.97

4.39

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.53

4.29

1.1

1.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

126

2.31

4.26

2.7

2.8

mu/l

16.6

19.7

0.48

117

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.51

4.20

1.1

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.51

4.20

1.1

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.75

4.18

1.9

1.5

ng/l

177.3

131.8

0.61

(3000494) Fungus identified in Specimen by Culture

488

4069

1.22

4.11

1.6

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

276

2156

1.30

4.07

2.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

169

2.08

4.00

1.2

5.9

mg/l

61.6

71.7

0.40

109

(3014891) Appearance of Pleural fluid

3.03

3.96

1.4

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.64

3.92

1.1

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

472

1.62

3.90

3.1

22.5

mmol/l

7.3

7.6

0.21

386

(1761482) Bacteria [#/volume] in Urine by Culture

160

1161

1.39

3.88

6.6

4.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.45

3.87

2.0

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

7.28

3.85

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

137

970

1.42

3.82

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.80

1.0

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

361

1.70

3.78

1.1

—

(3011648) Oxygen content in Venous blood

309

1.76

3.76

3.0

2.1

9.8

11.0

1.22

309

(3000330) Specific gravity of Urine by Test strip

272

2145

1.28

3.76

5.5

3.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

202

1.94

3.71

2.7

1.6

u/l

395.3

2503.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

964

8595

1.15

3.71

1.8

nmol/l

1202.7

1150.9

0.72

733

6403

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

168

2.03

3.69

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

168

2.03

3.69

1.1

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.12

3.64

2.4

2.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.61

3.63

1.0

1.2

umol/24h

0.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

150

2.07

3.56

1.3

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

150

2.07

3.56

1.3

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

136

976

1.41

3.55

1.1

—

(3016038) Potassium [Moles/volume] in Urine

264

1.79

3.51

1.1

mmol/l

35.7

34.6

0.11

218

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.54

3.46

1.3

1.2

mmol/l

1.8

1.4

0.63

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

151

2031

0.73

3.44

2.0

1.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

136

982

1.40

3.43

1.1

1.2

—

(3044927) Protein electrophoresis panel - Urine

489

1.56

3.42

1.3

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

506

1.55

3.39

2.3

mg/l

14.5

23.4

2.22

122

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.51

3.37

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

320

1.70

3.37

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

168

1.97

3.33

1.2

1.3

—

(40768443) Skin Pathology biopsy report

189

1448

1.32

3.28

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

109

2.21

3.24

1.4

1.2

umol/l

31.7

28.6

0.69

104

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.39

3.22

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

6.37

3.18

8.6

5.4

umol/l

501.3

383.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.96

3.13

1.5

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.47

3.12

1.1

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

223

1.80

3.10

1.1

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

183

1410

1.31

3.07

1.4

1.8

u/l

36.2

37.8

0.46

153

1182

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

958

0.64

3.05

1.5

1.6

mg/l

5.6

4.3

0.41

667

(3025549) Creatine [Moles/time] in 24 hour Urine

3.45

3.04

2.3

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.89

3.02

2.1

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

4.29

2.99

4.3

3.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

264

1.71

2.95

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

310

1.65

2.94

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

4.71

2.91

1.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

116

841

1.39

2.91

1.1

1.2

titre

91.3

108.8

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

170

1.89

2.89

1.1

u/l

128.6

88.1

0.50

127

(3007461) Platelets [#/volume] in Blood

4020

39341

1.15

2.88

43.0

20.8

e9/l

245.4

239.0

6.84

3938

38010

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3434

35346

0.89

2.87

4.8

mmol/l

1.3

1.4

29.66

3094

32112

(3007164) IgA [Mass/volume] in Serum or Plasma

644

5681

1.15

2.86

1.5

1.3

g/l

2.5

2.7

0.82

390

3210

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

171

1.88

2.85

1.1

u/l

77.7

25.9

0.65

123

(3024731) MCV [Entitic volume]

4020

39350

1.15

2.83

42.7

20.8

91.3

91.5

3.36

3967

38532

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

489

4231

1.17

2.79

2.5

2.4

ug/l

5.0

7.5

3.90

425

3659

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.45

2.79

4.9

3.6

—

(3000963) Hemoglobin [Mass/volume] in Blood

4020

39359

1.15

2.78

43.1

21.0

g/l

128.5

136.4

159.06

3971

38554

(3035941) MCH [Entitic mass]

4019

39351

1.15

2.77

42.7

20.7

30.1

30.5

32.55

3966

38535

(3010813) Leukocytes [#/volume] in Blood

4020

39363

1.15

2.76

43.0

20.9

e9/l

7.3

6.8

26.35

3921

37867

(3026361) Erythrocytes [#/volume] in Blood

4019

39354

1.15

2.76

42.9

20.8

e12/l

4.3

4.5

66.64

3918

37860

(3000012) Reticulocyte production index

217

1.76

2.75

1.4

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

8.34

2.75

1.2

1.7

ng/l

76.7

12.2

—

(3022475) Manganese [Moles/volume] in Blood

8.34

2.75

1.6

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.71

3.5

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

117

861

1.37

2.71

2.6

2.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

568

1.45

2.68

3.3

2.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3470

35655

0.90

2.67

4.8

4.9

mmol/l

4.3

4.4

6.38

3141

32630

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

140

1.93

2.64

2.6

2.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

392

1.54

2.60

3.2

3.8

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.73

2.54

1.3

1.2

u/l

22.6

14.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3567

36568

0.90

2.53

5.3

5.5

mmol/l

2.5

2.6

7.01

3198

33307

(3023419) Bacteria identified in Sputum by Culture

529

1.44

2.45

2.0

2.5

—

(3023410) Appearance of Cerebral spinal fluid

296

1.59

2.41

1.5

1.4

—

(4034850)

100

1347

0.74

2.40

16.3

10.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

118

1.95

2.35

1.4

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.86

2.30

1.1

1.2

umol/24h

2.0

1.9

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1102

10184

1.11

2.29

3.2

2.8

ug/l

0.9

0.7

3.23

814

7083

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.62

2.27

1.2

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.48

2.27

1.9

4.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

216

1.67

2.25

1.2

1.3

nmol/l

1.6

1.2

0.41

161

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

179

1.74

2.22

1.5

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

179

1.74

2.22

1.5

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.56

2.21

6.2

5.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

2.13

2.18

1.4

umol/l

2.2

2.0

0.46

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.71

2.10

1.2

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3336

34197

0.92

2.01

4.3

mmol/l

1.5

1.3

26.55

2965

30795

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.08

2.01

2.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

298

3467

0.85

2.00

1.5

—

(21494434) Karyotype in Bone marrow

303

1.52

2.00

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.82

2.00

1.2

1.1

—

(3019977) pH of Arterial blood

233

1.59

1.95

2.1

2.2

7.4

0.42

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

666

1.34

1.95

1.7

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

150

1207

1.25

1.91

1.4

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.05

1.90

1.9

3.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.16

1.87

2.0

1.4

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

2.21

1.84

2.0

1.4

u/l

15.8

42.0

0.51

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

4.17

1.82

4.8

1.1

nmol/l

2.2

3.2

—

(3034770) Mitochondria Ab [Titer] in Serum

110

858

1.29

1.82

1.1

1.2

titre

686.7

1189.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.57

1.80

1.1

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.92

1.79

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

169

1.66

1.76

1.1

1.2

nmol/l

130.2

143.7

1.04

169

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

349

0.57

1.75

1.1

1.0

ng/l

557.8

708.7

1.25

220

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

349

0.57

1.75

1.1

1.0

ng/l

34.1

46.4

0.94

220

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.88

1.70

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

104

1.83

1.67

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

597

1.33

1.66

1.3

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.16

1.66

1.0

1.2

—

(3048879) Bone marrow aspiration report

1.89

1.65

1.4

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

318

1.45

1.63

1.3

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

420

3750

1.13

1.63

1.3

1.4

—

(3008898) HLA-B27 [Presence]

816

0.73

1.63

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

959

8946

1.09

1.62

1.8

1.7

pmol/l

16240823.8

27652664.9

0.29

782

7258

(3044242) Glucose [Moles/volume] in Arterial blood

229

1.53

1.62

1.6

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.00

1.58

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.00

1.58

2.7

1.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.69

1.58

3.1

3.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

2.69

1.58

6.3

7.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

118

956

1.24

1.48

1.4

g/l

0.3

0.2

2.32

113

903

(3004716) Salmonella sp identified in Stool by Organism specific culture

157

1312

1.20

1.46

1.2

1.3

—

(3017569) Oxygen content in Arterial blood

235

1.49

1.46

1.9

1.8

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.12

1.44

3.0

2.7

u/field

0.3

0.13

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

120

979

1.23

1.42

1.4

g/l

1.2

1.60

115

923

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.18

1.39

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

166

1.57

1.37

1.1

—

(4133840)

1.83

1.35

1.3

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

119

977

1.22

1.35

1.7

1.6

iu/ml

0.9

3.4

0.42

221

(3014271) Vancomycin [Susceptibility]

258

1.44

1.31

2.6

3.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.50

1.30

1.0

—

(3037522) Nuclear Ab [Titer] in Serum

481

4395

1.11

1.29

1.2

1.3

titre

502.6

520.0

0.06

945

(3002619) Bacteria identified in Specimen by Culture

2.00

1.27

1.8

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.22

1.24

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

290

0.62

1.23

1.4

pmol/l

87.3

180.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.63

1.21

1.0

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

141

1.56

1.17

1.0

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

669

1.24

1.15

1.1

1.2

u/ml

4.3

6.2

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

0.00

1.15

0.0

1.1

—

26.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.73

1.15

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

413

1.31

1.13

3.4

3.0

mg/l

81.2

36.0

1.03

313

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1525

14651

1.06

1.12

4.4

3.9

22.9

24.3

2.79

812

7272

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

217

1.43

1.11

2.3

2.5

—

(3032057) Clostridioides difficile [Presence] in Stool

1.67

1.04

1.8

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.63

1.03

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

108

0.46

1.00

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

108

0.46

1.00

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

108

0.46

1.00

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

108

0.46

1.00

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.88

1.00

1.1

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

147

1.50

1.00

1.3

2.3

105.0

94.3

0.57

136

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.00

1.00

1.7

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

655

1.23

0.99

1.3

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.62

0.99

1.1

—

(4015189)

131

1.53

0.99

2.4

2.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

123

1.55

0.99

1.2

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

352

1.31

0.99

1.5

1.9

—

(4024509)

388

1.29

0.97

1.3

1.6

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

(4306422)

398

1.28

0.96

1.1

1.2

—

(3016879) Cocaine [Presence] in Urine

425

1.27

0.95

1.5

1.9

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.89

0.94

1.0

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

134

1158

1.16

0.94

1.6

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.22

0.93

1.3

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.82

0.92

1.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

392

1.28

0.92

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

495

5306

0.93

0.91

12.5

7.5

—

(4094501)

1068

0.84

0.90

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.91

0.88

1.1

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

119

1.51

0.88

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

525

5604

0.93

0.87

1.2

1.3

iu/ml

40.5

39.3

0.05

163

1694

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

237

1.35

0.87

2.3

2.1

ug/min

179.4

201.9

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

323

0.71

0.87

1.0

1.1

u/ml

0.8

1.1

—

139

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

203

1.38

0.87

1.5

1.4

u/l

6.2

6.6

0.22

170

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.00

0.87

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

537

0.78

0.85

1.3

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

415

1.26

0.84

1.8

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.94

0.84

1.2

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.78

0.84

1.9

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

492

5253

0.93

0.83

1.2

u/ml

16.3

15.3

0.08

162

1909

(3028707) Methadone [Presence] in Urine by Screen method

222

1.35

0.83

1.5

2.2

—

(3048689) Calprotectin [Mass/mass] in Stool

383

3551

1.09

0.82

2.3

2.2

ug/g

258.4

161.6

0.85

295

2776

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

122

1.48

0.80

1.9

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

122

1.48

0.80

1.9

2.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

303

1.29

0.79

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.67

0.78

1.8

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.67

0.78

1.1

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.78

0.0

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

474

0.78

1.1

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

278

1.30

0.77

1.1

—

(3027008) Opiates [Presence] in Urine

457

1.23

0.77

1.4

1.8

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.76

0.0

1.1

—

(4062490)

332

1.27

0.76

1.0

1.4

—

(3028300) Cannabinoids [Presence] in Urine

458

1.23

0.75

1.4

1.8

—

(3052592) Norovirus Ag [Presence] in Stool

1.54

0.75

1.1

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

819

0.84

0.73

1.7

1.6

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

1.61

0.72

1.2

131.4

108.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.62

0.71

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

453

1.22

0.71

1.5

1.9

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.92

0.70

1.2

1.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

508

1.20

0.70

1.3

1.7

g/l

0.9

0.02

388

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

146

0.62

0.69

1.4

1.8

ug/l

26.0

72.0

—

135

(3001019) Free T4 and TSH panel - Serum or Plasma

866

0.85

0.68

1.6

1.7

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

153

1.37

0.67

1.1

1.2

ratio

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.79

0.66

1.4

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.79

0.66

1.4

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.79

0.66

1.4

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

283

0.74

0.66

1.0

1.1

u/ml

2.1

2.0

—

(3000492) Spirometry study

323

3008

1.08

0.66

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

328

0.76

0.66

1.0

1.1

u/ml

6.6

3.8

—

160

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

449

1.21

0.65

1.0

1.2

miu/ml

138.3

191.1

0.49

159

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

286

1.26

0.65

1.2

titre

217.1

170.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

304

1.25

0.65

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

137

1226

1.12

0.64

1.5

1.7

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

177

0.68

0.63

1.3

1.4

—

1.5

—

(3006270) Folate [Moles/volume] in Blood

378

1.22

0.62

1.3

1.2

nmol/l

315.7

336.6

0.29

293

(3027135) IgG subclass 1 [Mass/volume] in Serum

333

1.23

0.62

1.0

1.4

g/l

6.8

6.9

0.03

233

(3024139) IgG subclass 3 [Mass/volume] in Serum

333

1.23

0.62

1.0

1.4

g/l

0.4

0.63

237

(3028192) IgG subclass 2 [Mass/volume] in Serum

333

1.23

0.62

1.0

1.4

g/l

2.5

3.0

0.65

235

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.67

0.61

1.0

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.57

0.60

1.3

1.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

244

0.74

0.60

1.1

u/ml

3.1

2.3

—

101

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

408

1.20

0.59

1.2

u/ml

5.6

5.3

0.05

186

(3021788) Differential panel - Synovial fluid

752

1.15

0.59

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

377

0.79

0.58

1.0

1.1

u/ml

2.6

1.6

0.20

161

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.46

0.58

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3418

34535

0.96

0.56

7.2

6.6

mmol/mol

41.4

41.0

1.48

3135

31585

(3027944) Amphetamines [Presence] in Urine

448

1.19

0.56

1.5

1.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

106

945

1.12

0.55

1.9

1.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

794

1.14

0.55

1.6

1.5

nmol/l

1.0

0.8

1.24

646

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.58

0.54

1.0

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.58

0.54

1.0

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.46

0.54

1.4

1.3

—

(3025577) Chromium [Mass/volume] in Blood

306

0.78

0.54

2.0

ug/l

2.8

1.9

0.30

256

(4268621)

276

1.23

0.53

2.2

2.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

151

1.33

0.53

2.4

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

150

1369

1.10

0.52

1.5

1.7

—

(3006462) Nitrate [Presence] in Urine

170

1.30

0.51

6.2

3.2

—

(3011288) Drugs identified in Urine by Screen method

287

1.22

0.51

2.2

2.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

242

1.24

0.50

1.9

1.8

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

206

1.26

0.50

3.0

4.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.47

0.50

1.0

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

110

0.64

0.48

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.52

0.48

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3532

35623

0.97

0.47

5.6

5.1

mmol/l

6.2

6.1

2.38

3168

31974

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

373

1.18

0.47

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.46

0.46

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

111

1.35

0.46

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.43

0.46

1.1

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.61

0.45

1.4

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

407

0.83

0.45

1.3

1.5

17.9

27.4

1.64

274

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.40

0.45

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

1.40

0.44

1.2

1.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1030

0.90

0.44

1.6

1.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

130

1.31

0.43

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

810

1.11

0.43

1.1

1.2

u/ml

3.1

5.6

—

132

(3026470) Cobalt [Mass/volume] in Blood

318

0.82

0.43

2.0

1.9

ug/l

8.9

3.3

0.36

279

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

157

1.28

0.43

1.2

1.3

—

(1002224) Polysomnography panel

1070

0.90

0.42

1.0

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

109

993

1.10

0.42

3.0

3.1

nmol/l

0.8

0.06

765

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.64

0.42

5.3

7.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

552

0.87

0.41

3.7

4.2

umol/l

316.2

349.8

0.97

463

(3005322) IgE [Units/volume] in Serum or Plasma

199

1865

1.07

0.40

1.3

u/ml

244.3

247.7

0.02

178

1726

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

549

1.13

0.40

1.0

1.1

iu/ml

1.5

376.9

0.72

113

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.40

0.0

1.6

—

1.3

—

(3033799) Differential panel - Peritoneal fluid

1.36

0.40

1.7

1.9

—

(40757373) Influenza virus identified in Isolate

1.36

0.40

1.9

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

160

0.75

0.39

1.1

1.2

—

(4211845)

187

1.23

0.38

6.0

3.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.35

0.37

1.9

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

430

0.86

0.37

1.4

1.2

e6/l

33143.2

221250.7

3.39

296

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.32

0.37

1.1

1.2

—

(3044941) Cell count panel - Synovial fluid

677

1.11

0.36

1.5

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

114

1235

0.92

0.36

1.2

u/ml

0.5

0.7

—

128

(44816559) Phosphatidylethanol [Mass/volume] in Blood

597

0.89

0.35

1.1

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

222

0.81

0.34

1.0

1.1

u/ml

9.8

3.4

—

(3029075) Extractable nuclear Ab panel - Serum

1.34

0.34

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

359

1.14

0.33

1.1

1.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.30

0.33

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

0.70

0.33

1.5

1.9

g/l

17.4

14.1

—

(40762814) Titanium [Mass/volume] in Blood

0.67

0.33

2.3

2.2

—

3.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.28

0.32

1.3

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

331

3446

0.96

0.31

1.6

1.8

1.6

0.03

273

2921

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

427

1.13

0.31

1.2

u/ml

5.4

4.3

0.11

130

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

208

0.82

0.31

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

802

1.09

0.30

1.1

1.2

u/ml

2.1

7.3

—

(3024263) Appearance of Synovial fluid

239

0.84

0.29

1.3

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

167

1579

1.06

0.29

1.4

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.29

0.28

1.3

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

150

1.20

0.26

1.2

1.1

u/l

1.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.70

0.26

1.6

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.30

0.26

1.3

1.2

105.1

100.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

751

1.08

0.26

1.2

mmol/l

4.0

0.06

698

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

138

0.80

0.25

1.4

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

383

0.89

0.25

1.4

1.9

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

424

0.90

0.24

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

133

1.20

0.24

1.3

1.6

umol/l

82.9

141.9

—

(44813793)

190

0.84

0.23

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.32

0.23

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.24

0.22

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.25

0.22

1.0

1.6

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

12.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

188

0.85

0.21

1.7

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

103

0.78

0.21

6.1

6.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

104

0.77

0.21

1.5

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

154

1.17

0.21

18.7

16.1

nmol/l

1486.1

1351.4

0.35

149

(3001729) Color of Synovial fluid

1.16

0.21

1.2

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

800

0.94

0.20

1.8

1.9

pmol/l

217.8

202.2

0.49

746

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.25

0.20

1.7

1.5

umol/l

50.8

44.3

—

(3045716) Anion gap in Serum or Plasma

221

1.13

0.20

2.4

2.2

mmol/l

7.8

9.4

1.58

169

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

269

2774

0.97

0.19

1.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.18

0.19

4.0

2.2

umol/l

45.7

45.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

109

1.19

0.18

1.8

2.5

ug/l

1.8

1.1

0.29

100

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

100

1.20

0.18

1.9

1.4

ug/l

12.5

9.2

1.06

100

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

406

1.08

0.17

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

258

0.89

0.17

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

176

1.14

0.17

1.1

1.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

678

6670

1.02

0.17

1.2

u/ml

1.7

2.0

0.19

155

1711

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

382

0.92

0.17

1.3

1.2

mmol/l

7.3

7.7

0.39

265

(3051387) C reactive protein [Mass/volume] in Capillary blood

884

0.95

0.16

4.2

3.7

mg/l

32.5

28.8

0.36

584

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

720

1.06

0.16

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

287

0.91

0.15

1.2

promille

1.4

1.3

0.20

224

(3003338) MCHC [Mass/volume]

2914

29280

0.99

0.15

38.8

18.8

g/l

329.6

332.6

50.86

2882

28994

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.79

0.15

1.0

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

0.78

0.15

1.0

2.2

mg/l

11.7

8.7

—

(3044007) Cell count panel - Peritoneal fluid

0.77

0.15

1.5

2.5

—

(3009871) Measles virus Ab [Titer] in Serum

1.14

0.15

1.6

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

136

1410

0.96

0.14

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

440

0.93

0.14

1.4

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

509

1.06

0.14

1.6

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.18

0.12

1.0

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

739

1.04

0.11

1.4

1.3

e6/l

578.5

788.3

0.21

615

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

739

1.04

0.11

1.3

e6/l

48.7

22.9

0.28

585

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

289

1.07

0.11

1.0

1.1

—

97.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.06

0.09

1.4

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.06

0.09

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

919

0.97

0.09

1.8

1.7

—

(3034426) Prothrombin time (PT)

1.13

0.09

1.0

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1001

9938

1.01

0.09

1.7

1.6

mmol/l

1.6

1.3

9.04

847

8191

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.05

0.08

1.2

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

214

1.08

0.08

1.1

nmol/l

0.2

8.9

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.82

0.08

1.0

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

318

0.94

0.08

1.4

titre

1124.0

326.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

226

0.93

0.08

1.8

1.2

u/ml

0.5

1.2

0.72

114

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

589

1.04

0.07

1.1

1.2

u/ml

54.7

42.1

0.34

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

137

1.10

0.07

1.1

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

469

0.96

0.07

1.5

1.9

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.88

0.06

1.9

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.88

0.06

1.9

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.89

0.06

1.1

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.87

0.06

1.9

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.87

0.06

1.9

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

142

0.92

0.06

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

113

1153

0.98

0.06

1.7

1.6

—

(4146454)

507

0.97

0.06

2.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

172

0.93

0.06

1.3

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

108

1059

1.02

0.05

1.6

1.5

e6/l

15726.1

13857.7

0.19

769

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

326

1.04

0.05

1.1

u/ml

11.9

3.1

—

113

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

778

0.98

0.05

1.1

u/ml

4.9

8.8

—

(3051593) INR in Capillary blood by Coagulation assay

238

1.05

0.05

11.2

11.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

535

1.03

0.05

1.6

1.5

74.5

63.3

1.77

359

(3022689) Creatine [Moles/volume] in Urine

130

0.92

0.04

1.6

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

111

1.08

0.04

20.5

7.6

—

(3020491) Glucose [Moles/volume] in Blood

289

1.04

0.04

1.9

2.3

mmol/l

8.4

6.8

1.46

195

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

220

0.95

0.03

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

220

0.95

0.03

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

220

0.95

0.03

1.0

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

359

1.03

0.03

1.5

1.7

u/ml

31.6

25.1

—

(4010399)

278

2760

1.01

0.03

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

717

1.02

0.03

1.2

1.3

—

(3015183) Erythrocyte sedimentation rate

108

0.93

0.03

1.3

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

112

1.07

0.03

1.1

miu/ml

775.1

1682.9

4.06

112

(3004616) Nuclear Ab [Presence] in Serum

430

1.02

0.02

1.0

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

227

2284

0.99

0.02

1.2

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

218

0.96

0.02

1.0

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

222

2208

1.01

0.02

2.3

2.4

au/ml

32.9

26.5

—

(3025130) Human papilloma virus identified in Specimen

167

0.96

0.01

1.8

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

217

0.97

0.01

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

217

0.97

0.01

1.0

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

497

4958

1.00

0.01

4.7

5.0

31.1

32.8

3.03

351

3254

(3032773) Endomysium IgG Ab [Titer] in Serum

263

1.03

0.01

1.0

1.1

—

(36660697) Celiac disease serology panel - Serum

242

2429

1.00

0.01

1.2

—

(3028433) Virus identified in Specimen by Culture

108

1.02

0.00

1.2

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

248

1.01

0.00

1.2

mmol/l

15.6

11.6

—

(4027681)

154

0.97

0.00

1.1

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

127

1.02

0.00

19.0

7.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

143

0.98

0.00

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

153

0.98

0.00

1.1

1.2

g/l

47.0

40.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

167

1.02

0.00

1.4

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

187

1.02

0.00

1.2

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

253

0.99

0.00

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

109

1.01

0.00

1.0

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

139

1.01

0.00

3.8

5.8

66.4

71.4

—

118

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.1

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.3

—

3.8

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(44806420)

150

1.00

0.00

2.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.94

0.00

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.4

—

0.2

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.5

—

35.9

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.98

0.00

1.9

1.5

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.00

0.00

1.9

1.4

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.92

0.00

1.8

1.5

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

0.95

0.00

1.1

1.5

238.5

196.9

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1215.0

—

(3005033) Fetal Nuchal fold Thickness US

1.01

0.00

1.9

1.4

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

0.94

0.00

1.0

1.1

—

6.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.97

0.00

1.1

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

0.91

0.00

1.5

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.98

0.00

1.1

1.5

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.5

—

1.6

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.2

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

8.6

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

2.6

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.0

1.0

—

176.8

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.95

0.00

1.0

1.1

—

(4198724)

0.99

0.00

1.1

1.7

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

235.3

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_URINARY_TRACT_EXALLC – Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

GWS hits: 9

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints